faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Fecal CD200 as a Measure of Immunosuppressive CD200L and Proinflammatory CD200S at the Feto-Maternal Interface.,American Journal of Reproductive Immunology,2025,10.1111/aji.70120,https://experts.mcmaster.ca/display/publication3601680,2025-07-27T15:10:54.977867
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of gut-brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis.,The Lancet Gastroenterology and Hepatology,2025,10.1016/S2468-1253(25)00051-2,https://experts.mcmaster.ca/display/publication3576371,2025-07-27T15:10:54.977872
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Cost-Effectiveness of Regular Surveillance Versus Endoscopy at Need for Patients With Barrett's Esophagus: Economic Evaluation Alongside the Barrett's Oesophagus Surveillance Study (BOSS) Randomized Controlled Trial.,Gastroenterology,2025,10.1053/j.gastro.2025.04.026,https://experts.mcmaster.ca/display/publication3587222,2025-07-27T15:10:54.977873
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Risk factors associated with Gastrointestinal Bleeding in Patients with Cardiovascular Disease (INTERBLEED): a case control study.,European Journal of Preventive Cardiology (EJPC),2025,10.1093/eurjpc/zwaf300,https://experts.mcmaster.ca/display/publication3585329,2025-07-27T15:10:54.977874
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise.,Nature Communications,2025,10.1038/s41467-025-58673-x,https://experts.mcmaster.ca/display/publication3568630,2025-07-27T15:10:54.977875
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Barrett's Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial.,Gastroenterology,2025,10.1053/j.gastro.2025.03.021,https://experts.mcmaster.ca/display/publication3568629,2025-07-27T15:10:54.977877
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply.,Gastroenterology,2025,10.1053/j.gastro.2025.01.001,https://experts.mcmaster.ca/display/publication3528812,2025-07-27T15:10:54.977878
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease.",Gastroenterology,2025,10.1053/j.gastro.2024.09.033,https://experts.mcmaster.ca/display/publication3515903,2025-07-27T15:10:54.977879
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Management of Patients With Refractory Reflux-Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence-Based Consensus Statements.,Alimentary Pharmacology and Therapeutics,2025,10.1111/apt.18420,https://experts.mcmaster.ca/display/publication3513483,2025-07-27T15:10:54.977880
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Symptoms in Persons With Either Active or Inactive Crohn's Disease Are Agnostic to Disease Phenotype: The Magic in Imagine Study.,Journal of Clinical Gastroenterology,2025,10.1097/MCG.0000000000002137,https://experts.mcmaster.ca/display/publication3535040,2025-07-27T15:10:54.977881
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication Therapy to Prevent Gastric Cancer in Helicobacterpylori-Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.,Gastroenterology,2025,10.1053/j.gastro.2024.12.033,https://experts.mcmaster.ca/display/publication3527096,2025-07-27T15:10:54.977882
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study",Inflammatory Bowel Diseases,2025,10.1093/ibd/izae055,https://experts.mcmaster.ca/display/publication3410480,2025-07-27T15:10:54.977883
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease.",Gastroenterology,2025,10.1053/j.gastro.2024.08.031,https://experts.mcmaster.ca/display/publication3466621,2025-07-27T15:10:54.977884
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease.",American Journal of Gastroenterology,2024,10.14309/ajg.0000000000003196,https://experts.mcmaster.ca/display/publication3488203,2025-07-27T15:10:54.977885
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome.,BMJ Open,2024,10.1136/bmjopen-2024-089220,https://experts.mcmaster.ca/display/publication3488435,2025-07-27T15:10:54.977886
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.,Gastroenterology,2024,10.1053/j.gastro.2024.06.038,https://experts.mcmaster.ca/display/publication3470208,2025-07-27T15:10:54.977887
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline.",The BMJ,2024,10.1136/bmj-2024-079830,https://experts.mcmaster.ca/display/publication3485968,2025-07-27T15:10:54.977888
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of theCOMPASSrandomised controlled trial",Alimentary Pharmacology and Therapeutics,2024,10.1111/apt.18139,https://experts.mcmaster.ca/display/publication3446600,2025-07-27T15:10:54.977889
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Impaired Epithelial CD200L Tolerance Signaling in Irritable Bowel Syndrome Cases With Diarrhea May Be Associated With Recurrent Miscarriages,American Journal of Reproductive Immunology,2024,10.1111/aji.13912,https://experts.mcmaster.ca/display/publication3458777,2025-07-27T15:10:54.977890
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Adverse Events Associated With Proton Pump Inhibitors: Fact vs Fiction.,Gastroenterology and Hepatology,2024,,https://experts.mcmaster.ca/display/publication3452400,2025-07-27T15:10:54.977892
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Studying How Patient Engagement Influences Research: A Mixed Methods Study,Patient,2024,10.1007/s40271-024-00685-8,https://experts.mcmaster.ca/display/publication3406673,2025-07-27T15:10:54.977893
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Effects of Pantoprazole on Kidney Outcomes,Journal of the American Society of Nephrology,2024,10.1681/asn.0000000000000356,https://experts.mcmaster.ca/display/publication3412903,2025-07-27T15:10:54.977894
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Two Years Gone,Gastroenterology,2024,10.1053/j.gastro.2024.03.020,https://experts.mcmaster.ca/display/publication3438825,2025-07-27T15:10:54.977895
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS),Neurogastroenterology and Motility,2024,10.1111/nmo.14817,https://experts.mcmaster.ca/display/publication3438826,2025-07-27T15:10:54.977896
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis,Gastroenterology,2024,10.1053/j.gastro.2024.05.010,https://experts.mcmaster.ca/display/publication3433087,2025-07-27T15:10:54.977897
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project",Clinical Gastroenterology and Hepatology,2024,10.1016/j.cgh.2024.03.049,https://experts.mcmaster.ca/display/publication3433088,2025-07-27T15:10:54.977898
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Measuring the Impact of Patient Engagement in Health Research: An Exploratory Study Using Multiple Survey Tools,Journal of the Canadian Association of Gastroenterology,2024,10.1093/jcag/gwad045,https://experts.mcmaster.ca/display/publication3414321,2025-07-27T15:10:54.977899
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Interactive training with a novel simulation model for upper gastrointestinal endoscopic hemostasis improves trainee technique and confidence,Endoscopy International Open,2024,10.1055/a-2248-5110,https://experts.mcmaster.ca/display/publication3402743,2025-07-27T15:10:54.977900
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease.,Journal of the Canadian Association of Gastroenterology,2024,10.1093/jcag/gwad052,https://experts.mcmaster.ca/display/publication3476434,2025-07-27T15:10:54.977901
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation,Therapeutic Advances in Chronic Disease,2024,10.1177/20406223241239168,https://experts.mcmaster.ca/display/publication3410479,2025-07-27T15:10:54.977902
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease,6 Ds of Fecal Microbiota Transplantation A Primer from Decision to Discharge and Beyond,2024,,https://experts.mcmaster.ca/display/publication3457186,2025-07-27T15:10:54.977903
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychosocial factors associated with j-pouch surgery for patients with IBD: a scoping review,Quality of Life Research,2023,10.1007/s11136-023-03454-6,https://experts.mcmaster.ca/display/publication3254977,2025-07-27T15:10:54.977904
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Exploring the outcomes of research engagement using the observation method in an online setting,BMJ Open,2023,10.1136/bmjopen-2023-073953,https://experts.mcmaster.ca/display/publication3317842,2025-07-27T15:10:54.977905
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Microbiota signatures and mucosal healing in the use of enteral nutrition therapyv. corticosteroids for the treatment of children with Crohn’s disease: a systematic review and meta-analysis,British Journal of Nutrition,2023,10.1017/s0007114523000405,https://experts.mcmaster.ca/display/publication2893692,2025-07-27T15:10:54.977906
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study",Clinical Gastroenterology and Hepatology,2023,10.1016/j.cgh.2022.11.037,https://experts.mcmaster.ca/display/publication2951618,2025-07-27T15:10:54.977907
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives,Gastroenterology,2023,10.1053/j.gastro.2023.05.032,https://experts.mcmaster.ca/display/publication3242730,2025-07-27T15:10:54.977908
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis,Gut,2023,10.1136/gutjnl-2022-328421,https://experts.mcmaster.ca/display/publication3009212,2025-07-27T15:10:54.977909
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Hemorrhage From Left Hepatic Artery Pseudoaneurysm as a Complication of Acute Pancreatitis in a Patient With Fibromuscular Dysplasia,ACG Case Reports Journal,2023,10.14309/crj.0000000000001098,https://experts.mcmaster.ca/display/publication3269195,2025-07-27T15:10:54.977910
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis,Clinical Gastroenterology and Hepatology,2023,10.1016/j.cgh.2022.05.041,https://experts.mcmaster.ca/display/publication2315431,2025-07-27T15:10:54.977911
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY,Gastroenterology,2023,,https://experts.mcmaster.ca/display/publication3385359,2025-07-27T15:10:54.977912
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Beyond the White Pill: Advocating for Racial Diversity in IBD Trials,Journal of Crohn's and Colitis,2023,10.1093/ecco-jcc/jjac134,https://experts.mcmaster.ca/display/publication2429670,2025-07-27T15:10:54.977913
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis,Gastroenterology,2023,10.1053/j.gastro.2022.12.042,https://experts.mcmaster.ca/display/publication2893693,2025-07-27T15:10:54.977914
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Working to Answer the Effectiveness of Nutrition in IBD: Still a Ways to Go,American Journal of Gastroenterology,2023,10.14309/ajg.0000000000002040,https://experts.mcmaster.ca/display/publication2835237,2025-07-27T15:10:54.977915
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia,Middle East Journal of Digestive Diseases,2023,10.34172/mejdd.2023.313,https://experts.mcmaster.ca/display/publication3009623,2025-07-27T15:10:54.977916
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease,European Journal of Gastroenterology and Hepatology,2022,10.1097/meg.0000000000002438,https://experts.mcmaster.ca/display/publication2472497,2025-07-27T15:10:54.977917
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease,Gastroenterology,2022,10.1053/j.gastro.2022.07.004,https://experts.mcmaster.ca/display/publication2445004,2025-07-27T15:10:54.977918
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events,JAMA network open,2022,10.1001/jamanetworkopen.2022.43201,https://experts.mcmaster.ca/display/publication2526018,2025-07-27T15:10:54.977919
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding,CJC OPEN,2022,10.1016/j.cjco.2022.08.002,https://experts.mcmaster.ca/display/publication2424789,2025-07-27T15:10:54.977920
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis,Middle East Journal of Digestive Diseases,2022,10.34172/mejdd.2022.299,https://experts.mcmaster.ca/display/publication2893383,2025-07-27T15:10:54.977921
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reduce unnecessary use of proton pump inhibitors,The BMJ,2022,10.1136/bmj-2021-069211,https://experts.mcmaster.ca/display/publication2445003,2025-07-27T15:10:54.977922
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy ofHelicobacter pylorieradication therapy for functional dyspepsia: updated systematic review and meta-analysis,Gut,2022,10.1136/gutjnl-2021-326583,https://experts.mcmaster.ca/display/publication2161174,2025-07-27T15:10:54.977923
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply,Alimentary Pharmacology and Therapeutics,2022,10.1111/apt.17197,https://experts.mcmaster.ca/display/publication2430857,2025-07-27T15:10:54.977924
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma,"Cancer Epidemiology, Biomarkers and Prevention",2022,10.1158/1055-9965.epi-22-0096,https://experts.mcmaster.ca/display/publication2424565,2025-07-27T15:10:54.977925
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Analytical frameworks in colorectal cancer guidelines: development of methods for systematic reviews, their application and practical guidance for their use",Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2022.06.005,https://experts.mcmaster.ca/display/publication2143047,2025-07-27T15:10:54.977926
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility,Nature Genetics,2022,10.1038/s41588-022-01156-2,https://experts.mcmaster.ca/display/publication2429669,2025-07-27T15:10:54.977927
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up,Gastroenterology,2022,10.1053/j.gastro.2022.05.027,https://experts.mcmaster.ca/display/publication2232360,2025-07-27T15:10:54.977928
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation,Gastroenterology,2022,10.1053/j.gastro.2022.05.037,https://experts.mcmaster.ca/display/publication2424944,2025-07-27T15:10:54.977929
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome,Alimentary Pharmacology and Therapeutics,2022,10.1111/apt.17179,https://experts.mcmaster.ca/display/publication2424564,2025-07-27T15:10:54.977930
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"A patient‐led, peer‐to‐peer qualitative study on the psychosocial relationship between young adults with inflammatory bowel disease and food",Health Expectations,2022,10.1111/hex.13488,https://experts.mcmaster.ca/display/publication2182171,2025-07-27T15:10:54.977931
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastroenterology: A New Editorial Team Coming to You From Around the World,Gastroenterology,2022,10.1053/j.gastro.2022.04.023,https://experts.mcmaster.ca/display/publication2192385,2025-07-27T15:10:54.977932
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Diarrhea during critical illness: a multicenter cohort study,Intensive Care Medicine,2022,10.1007/s00134-022-06663-8,https://experts.mcmaster.ca/display/publication2184006,2025-07-27T15:10:54.977934
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis,Cochrane Database of Systematic Reviews,2022,10.1002/14651858.cd009662.pub3,https://experts.mcmaster.ca/display/publication2181183,2025-07-27T15:10:54.977935
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease,Journal of the Canadian Association of Gastroenterology,2022,10.1093/jcag/gwab008,https://experts.mcmaster.ca/display/publication1970150,2025-07-27T15:10:54.977936
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding,Cochrane Database of Systematic Reviews,2022,10.1002/14651858.cd005415.pub4,https://experts.mcmaster.ca/display/publication2161173,2025-07-27T15:10:54.977937
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reliability and Validation of the Persian Version of JUICE Study Questionnaire,Archives of Iranian Medicine,2022,10.34172/aim.2022.01,https://experts.mcmaster.ca/display/publication2169531,2025-07-27T15:10:54.977938
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis: A Qualitative Assessment of Patient Perceptions and Experiences,Journal of the Canadian Association of Gastroenterology,2021,10.1093/jcag/gwab007,https://experts.mcmaster.ca/display/publication2165448,2025-07-27T15:10:54.977939
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton Pump Inhibitor Use: A Risk Factor for Inflammatory Bowel Disease or an Innocent Bystander?,Gastroenterology,2021,10.1053/j.gastro.2021.09.005,https://experts.mcmaster.ca/display/publication2132391,2025-07-27T15:10:54.977940
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study,European Journal of Gastroenterology and Hepatology,2021,10.1097/meg.0000000000002186,https://experts.mcmaster.ca/display/publication1970370,2025-07-27T15:10:54.977941
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk",Gastroenterology,2021,10.1053/j.gastro.2021.07.009,https://experts.mcmaster.ca/display/publication2026326,2025-07-27T15:10:54.977942
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG",Clinical Gastroenterology and Hepatology,2021,10.1016/j.cgh.2020.08.040,https://experts.mcmaster.ca/display/publication1923569,2025-07-27T15:10:54.977943
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial,Journal of the Canadian Association of Gastroenterology,2021,10.1093/jcag/gwaa037,https://experts.mcmaster.ca/display/publication2132392,2025-07-27T15:10:54.977944
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study,Gastroenterology,2021,10.1053/j.gastro.2021.06.007,https://experts.mcmaster.ca/display/publication1981841,2025-07-27T15:10:54.977945
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Correction to: Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,American Journal of Gastroenterology,2021,10.14309/ajg.0000000000001371,https://experts.mcmaster.ca/display/publication1993350,2025-07-27T15:10:54.977946
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis,Cochrane Database of Systematic Reviews,2021,10.1002/14651858.cd009643.pub2,https://experts.mcmaster.ca/display/publication2122537,2025-07-27T15:10:54.977947
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Results of the First Pilot Randomized Controlled Trial of Fecal Microbiota Transplant In Pediatric Ulcerative Colitis: Lessons, Limitations, and Future Prospects",Gastroenterology,2021,10.1053/j.gastro.2021.04.067,https://experts.mcmaster.ca/display/publication1968754,2025-07-27T15:10:54.977948
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study,The BMJ,2021,10.1136/bmj.n1554,https://experts.mcmaster.ca/display/publication2010132,2025-07-27T15:10:54.977949
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma,Carcinogenesis,2021,10.1093/carcin/bgaa132,https://experts.mcmaster.ca/display/publication1940300,2025-07-27T15:10:54.977950
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis,Gastroenterology,2021,10.1053/j.gastro.2020.12.004,https://experts.mcmaster.ca/display/publication1941081,2025-07-27T15:10:54.977951
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology,Journal of the Canadian Association of Gastroenterology,2021,10.1093/jcag/gwaa046,https://experts.mcmaster.ca/display/publication1960730,2025-07-27T15:10:54.977952
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Current Status of Chemoprevention in Barrett’s Esophagus,Gastrointestinal Endoscopy Clinics of North America,2021,10.1016/j.giec.2020.08.008,https://experts.mcmaster.ca/display/publication1936774,2025-07-27T15:10:54.977953
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms,Alimentary Pharmacology and Therapeutics,2021,10.1111/apt.16184,https://experts.mcmaster.ca/display/publication1940291,2025-07-27T15:10:54.977954
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Leaving No Stone Unturned in the Search for Adverse Events Associated With Use of Proton Pump Inhibitors,Clinical Gastroenterology and Hepatology,2021,10.1016/j.cgh.2020.04.053,https://experts.mcmaster.ca/display/publication1895942,2025-07-27T15:10:54.977955
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Patients’ Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach,Clinical and Experimental Gastroenterology,2021,10.2147/ceg.s303688,https://experts.mcmaster.ca/display/publication1967882,2025-07-27T15:10:54.977956
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients,Frontiers in Physiology,2021,10.3389/fphys.2021.645303,https://experts.mcmaster.ca/display/publication1966867,2025-07-27T15:10:54.977957
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic review and network meta‐analysis: efficacy of drugs for functional dyspepsia,Alimentary Pharmacology and Therapeutics,2021,10.1111/apt.16072,https://experts.mcmaster.ca/display/publication1925986,2025-07-27T15:10:54.977958
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylorieradication therapy to prevent gastric cancer: systematic review and meta-analysis,Gut,2020,10.1136/gutjnl-2020-320839,https://experts.mcmaster.ca/display/publication1701872,2025-07-27T15:10:54.977959
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects,BMC Medical Genetics,2020,10.1186/s12881-020-01115-w,https://experts.mcmaster.ca/display/publication1936282,2025-07-27T15:10:54.977960
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease,Gastroenterology,2020,10.1053/j.gastro.2020.08.005,https://experts.mcmaster.ca/display/publication1922861,2025-07-27T15:10:54.977961
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Who Needs Gastroprotection in 2020?,Current Treatment Options in Gastroenterology,2020,10.1007/s11938-020-00316-9,https://experts.mcmaster.ca/display/publication1939098,2025-07-27T15:10:54.977962
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,IMAGINE Network’s Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome,BMJ Open,2020,10.1136/bmjopen-2020-041733,https://experts.mcmaster.ca/display/publication1935759,2025-07-27T15:10:54.977963
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,American Journal of Gastroenterology,2020,10.14309/ajg.0000000000000749,https://experts.mcmaster.ca/display/publication1920048,2025-07-27T15:10:54.977964
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis,Gastroenterology,2020,10.1053/j.gastro.2020.05.016,https://experts.mcmaster.ca/display/publication1903573,2025-07-27T15:10:54.977965
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis,Journal of Gastroenterology,2020,10.1007/s00535-020-01685-9,https://experts.mcmaster.ca/display/publication1703700,2025-07-27T15:10:54.977966
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylorieradication for the prevention of gastric neoplasia,Cochrane Database of Systematic Reviews,2020,10.1002/14651858.cd005583.pub3,https://experts.mcmaster.ca/display/publication1917231,2025-07-27T15:10:54.977967
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Evidence-based and mechanistic insights into exclusion diets for IBS,Nature Reviews Gastroenterology and Hepatology,2020,10.1038/s41575-020-0270-3,https://experts.mcmaster.ca/display/publication1695633,2025-07-27T15:10:54.977968
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,How to advise patients on the risk of chronic proton pump inhibitor therapy,Current Opinion in Gastroenterology,2020,10.1097/mog.0000000000000641,https://experts.mcmaster.ca/display/publication1914483,2025-07-27T15:10:54.977969
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Peppermint Oil in Irritable Bowel Syndrome,Gastroenterology,2020,10.1053/j.gastro.2019.09.055,https://experts.mcmaster.ca/display/publication1703701,2025-07-27T15:10:54.977970
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease,Journal of the Canadian Association of Gastroenterology,2020,10.1093/jcag/gwaa004,https://experts.mcmaster.ca/display/publication1813208,2025-07-27T15:10:54.977971
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review,Gastroenterology,2020,10.1053/j.gastro.2019.11.294,https://experts.mcmaster.ca/display/publication1683273,2025-07-27T15:10:54.977972
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2020,10.1053/j.gastro.2019.12.023,https://experts.mcmaster.ca/display/publication1686914,2025-07-27T15:10:54.977973
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis",The Lancet Gastroenterology and Hepatology,2020,10.1016/s2468-1253(19)30324-3,https://experts.mcmaster.ca/display/publication1684914,2025-07-27T15:10:54.977974
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data,Gastroenterology,2020,10.1053/j.gastro.2019.10.023,https://experts.mcmaster.ca/display/publication1676931,2025-07-27T15:10:54.977974
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Development of a Global Rating Scale for Inflammatory Bowel Disease,Journal of the Canadian Association of Gastroenterology,2020,10.1093/jcag/gwz017,https://experts.mcmaster.ca/display/publication1993363,2025-07-27T15:10:54.977975
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease,Journal of the Canadian Association of Gastroenterology,2020,10.1093/jcag/gwz035,https://experts.mcmaster.ca/display/publication1689180,2025-07-27T15:10:54.977976
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylorieradication for the prevention of gastric neoplasia,Cochrane Database of Systematic Reviews,2020,10.1002/14551858.00005583.pub3,https://experts.mcmaster.ca/display/publication1936192,2025-07-27T15:10:54.977978
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Controversies Around Measuring Drug Toxicity: US Food and Drug Administration and Gastrointestinal Perspectives,Gastroenterology,2020,10.1053/j.gastro.2019.10.014,https://experts.mcmaster.ca/display/publication1686872,2025-07-27T15:10:54.977979
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis,Gut,2020,10.1136/gutjnl-2018-318160,https://experts.mcmaster.ca/display/publication1639827,2025-07-27T15:10:54.977979
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Is Blood Urea Concentration an Independent Predictor of Positive Endoscopic Findings in Presumed Upper Gastrointestinal Bleeding?,Digestive Diseases,2020,10.1159/000501549,https://experts.mcmaster.ca/display/publication1654095,2025-07-27T15:10:54.977980
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2020,10.1053/j.gastro.2019.10.032,https://experts.mcmaster.ca/display/publication1676915,2025-07-27T15:10:54.977981
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem",Current Gastroenterology Reports,2019,10.1007/s11894-019-0732-3,https://experts.mcmaster.ca/display/publication1683379,2025-07-27T15:10:54.977983
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis,Circulation,2019,10.1161/circulationaha.119.041949,https://experts.mcmaster.ca/display/publication1665422,2025-07-27T15:10:54.977984
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn’s Disease,Inflammatory Bowel Diseases,2019,10.1093/ibd/izz116,https://experts.mcmaster.ca/display/publication1648140,2025-07-27T15:10:54.977985
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease,ACP journal club,2019,10.7326/acpj201910150-045,https://experts.mcmaster.ca/display/publication1747266,2025-07-27T15:10:54.977986
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Faecal microbiota transplantation for IBS: still a long way to go,The Lancet Gastroenterology and Hepatology,2019,10.1016/s2468-1253(19)30226-2,https://experts.mcmaster.ca/display/publication1654147,2025-07-27T15:10:54.977987
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin",Gastroenterology,2019,10.1053/j.gastro.2019.05.056,https://experts.mcmaster.ca/display/publication1644616,2025-07-27T15:10:54.977987
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton-pump inhibitors for the prevention of upper gastrointestinal bleeding in adults receiving antithrombotic therapy,Cochrane Database of Systematic Reviews,2019,10.1002/14651858.cd013415,https://experts.mcmaster.ca/display/publication2088768,2025-07-27T15:10:54.977989
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease,Clinical Gastroenterology and Hepatology,2019,10.1016/j.cgh.2019.02.043,https://experts.mcmaster.ca/display/publication1633252,2025-07-27T15:10:54.977990
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease,Gastroenterology,2019,10.1053/j.gastro.2019.03.022,https://experts.mcmaster.ca/display/publication1654145,2025-07-27T15:10:54.977991
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Editorial: the overlap between dyspepsia and gastro‐oesophageal reflux—is duodenal eosinophilia the missing link?,Alimentary Pharmacology and Therapeutics,2019,10.1111/apt.15388,https://experts.mcmaster.ca/display/publication1658705,2025-07-27T15:10:54.977992
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial",Gastroenterology,2019,10.1053/j.gastro.2019.04.041,https://experts.mcmaster.ca/display/publication1640412,2025-07-27T15:10:54.977993
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitors and gastric cancer: association is not causation,Gut,2019,10.1136/gutjnl-2018-316958,https://experts.mcmaster.ca/display/publication1564519,2025-07-27T15:10:54.977994
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Letter by Moulton et al.,Inflammatory Bowel Diseases,2019,10.1093/ibd/izz035,https://experts.mcmaster.ca/display/publication1631396,2025-07-27T15:10:54.977995
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease,Journal of the Canadian Association of Gastroenterology,2019,10.1093/jcag/gwz019,https://experts.mcmaster.ca/display/publication1649784,2025-07-27T15:10:54.977997
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease,Journal of the Canadian Association of Gastroenterology,2019,10.1093/jcag/gwz018,https://experts.mcmaster.ca/display/publication1652860,2025-07-27T15:10:54.977998
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gut Microbiota and Irritable Bowel Syndrome,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication1646718,2025-07-27T15:10:54.977999
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review,Gastroenterology,2019,10.1053/j.gastro.2019.03.049,https://experts.mcmaster.ca/display/publication1636046,2025-07-27T15:10:54.978000
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease,Inflammatory Bowel Diseases,2019,10.1093/ibd/izy385,https://experts.mcmaster.ca/display/publication1618926,2025-07-27T15:10:54.978001
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study",BMJ Open,2019,10.1136/bmjopen-2018-028237,https://experts.mcmaster.ca/display/publication1647312,2025-07-27T15:10:54.978002
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Letter: meta‐analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors’ reply",Alimentary Pharmacology and Therapeutics,2019,10.1111/apt.15234,https://experts.mcmaster.ca/display/publication1637339,2025-07-27T15:10:54.978003
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS),Journal of the Canadian Association of Gastroenterology,2019,10.1093/jcag/gwy071,https://experts.mcmaster.ca/display/publication1649844,2025-07-27T15:10:54.978004
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same Data,Journal of the Canadian Association of Gastroenterology,2019,10.1093/jcag/gwy072,https://experts.mcmaster.ca/display/publication1649845,2025-07-27T15:10:54.978005
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials,American Journal of Gastroenterology,2019,10.1038/s41395-018-0258-6,https://experts.mcmaster.ca/display/publication1604098,2025-07-27T15:10:54.978006
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus,Inflammatory Bowel Diseases,2019,10.1093/ibd/izy247,https://experts.mcmaster.ca/display/publication1586005,2025-07-27T15:10:54.978007
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2019,10.1038/s41395-018-0222-5,https://experts.mcmaster.ca/display/publication1590014,2025-07-27T15:10:54.978008
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Canadian Association of Gastroenterology Statement on the Putative Link
          Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter
            pylori Eradication",Journal of the Canadian Association of Gastroenterology,2018,10.1093/jcag/gwy040,https://experts.mcmaster.ca/display/publication1654125,2025-07-27T15:10:54.978009
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Clinical Practice Guideline for the Medical Management of Perianal
          Fistulizing Crohn’s Disease: The Toronto Consensus",Journal of the Canadian Association of Gastroenterology,2018,10.1093/jcag/gwy047,https://experts.mcmaster.ca/display/publication1682876,2025-07-27T15:10:54.978010
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis,Gastroenterology,2018,10.1053/j.gastro.2018.08.021,https://experts.mcmaster.ca/display/publication1590013,2025-07-27T15:10:54.978011
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Imipramine for functional dyspepsia: a 60-year journey,The Lancet Gastroenterology and Hepatology,2018,10.1016/s2468-1253(18)30338-8,https://experts.mcmaster.ca/display/publication1604099,2025-07-27T15:10:54.978012
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis,BMC Pregnancy and Childbirth,2018,10.1186/s12884-017-1629-5,https://experts.mcmaster.ca/display/publication1489012,2025-07-27T15:10:54.978013
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome",Alimentary Pharmacology and Therapeutics,2018,10.1111/apt.15001,https://experts.mcmaster.ca/display/publication1600036,2025-07-27T15:10:54.978014
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Prokinetics for functional dyspepsia,Cochrane Database of Systematic Reviews,2018,10.1002/14651858.cd009431.pub3,https://experts.mcmaster.ca/display/publication1604097,2025-07-27T15:10:54.978015
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups,Gastroenterology Nursing,2018,10.1097/sga.0000000000000338,https://experts.mcmaster.ca/display/publication1595902,2025-07-27T15:10:54.978016
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPS Diet in Treating Symptoms of Irritable Bowel Syndrome,American Journal of Gastroenterology,2018,10.1038/s41395-018-0195-4,https://experts.mcmaster.ca/display/publication1580550,2025-07-27T15:10:54.978017
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial,The Lancet,2018,10.1016/s0140-6736(18)31388-6,https://experts.mcmaster.ca/display/publication1577667,2025-07-27T15:10:54.978018
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects,Gut Microbes,2018,10.1080/19490976.2018.1445956,https://experts.mcmaster.ca/display/publication1507802,2025-07-27T15:10:54.978019
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines forClostridium difficileinfection,Journal of the Association of Medical Microbiology and Infectious Disease Canada,2018,10.3138/jammi.2018.02.13,https://experts.mcmaster.ca/display/publication1747267,2025-07-27T15:10:54.978020
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome,American Journal of Gastroenterology,2018,10.1038/s41395-018-0084-x,https://experts.mcmaster.ca/display/publication1561012,2025-07-27T15:10:54.978021
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial",The Lancet,2018,10.1016/s0140-6736(18)30832-8,https://experts.mcmaster.ca/display/publication1553106,2025-07-27T15:10:54.978022
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Marlicz et al,American Journal of Gastroenterology,2018,10.1038/s41395-018-0034-7,https://experts.mcmaster.ca/display/publication1507803,2025-07-27T15:10:54.978023
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Update on Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Disease.,Gastroenterology and Hepatology,2018,,https://experts.mcmaster.ca/display/publication1570299,2025-07-27T15:10:54.978024
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Signature Celebration of Gastroenterology , Colorectal Cancer",Gastroenterology,2018,10.1053/j.gastro.2017.11.029,https://experts.mcmaster.ca/display/publication1481039,2025-07-27T15:10:54.978025
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2018,10.1053/j.gastro.2018.01.022,https://experts.mcmaster.ca/display/publication1492061,2025-07-27T15:10:54.978026
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry,Frontiers in Physiology,2018,10.3389/fphys.2018.01248,https://experts.mcmaster.ca/display/publication1595826,2025-07-27T15:10:54.978027
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton Pump Inhibitors and Dementia: Deciphering the Data,American Journal of Gastroenterology,2017,10.1038/ajg.2017.415,https://experts.mcmaster.ca/display/publication1483877,2025-07-27T15:10:54.978028
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitors for functional dyspepsia,Cochrane Database of Systematic Reviews,2017,10.1002/14651858.cd011194.pub3,https://experts.mcmaster.ca/display/publication1479683,2025-07-27T15:10:54.978029
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Prokinetics for functional dyspepsia,Cochrane Database of Systematic Reviews,2017,10.1002/14651858.cd009431.pub2,https://experts.mcmaster.ca/display/publication1734799,2025-07-27T15:10:54.978030
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease,New England Journal of Medicine,2017,10.1056/nejmoa1709118,https://experts.mcmaster.ca/display/publication1446780,2025-07-27T15:10:54.978031
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma,Gut,2017,10.1136/gutjnl-2016-311622,https://experts.mcmaster.ca/display/publication1040502,2025-07-27T15:10:54.978032
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice,United European Gastroenterology Journal,2017,10.1177/2050640617731968,https://experts.mcmaster.ca/display/publication1466932,2025-07-27T15:10:54.978033
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic Review and Meta-analysis,Inflammatory Bowel Diseases,2017,10.1097/mib.0000000000001228,https://experts.mcmaster.ca/display/publication1458956,2025-07-27T15:10:54.978034
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia,American Journal of Gastroenterology,2017,10.1038/ajg.2017.238,https://experts.mcmaster.ca/display/publication1460637,2025-07-27T15:10:54.978035
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.,Inflammatory Bowel Diseases,2017,10.1097/MIB.0000000000001228,https://experts.mcmaster.ca/display/publication1458955,2025-07-27T15:10:54.978036
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Faecal microbiota transplantation forClostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.,Clostridium difficile,2017,10.5694/mja17.00295,https://experts.mcmaster.ca/display/publication1447168,2025-07-27T15:10:54.978037
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Faecal microbiota transplantation forClostridium difficile‐associated diarrhoea: a systematic review of randomised controlled trials,Medical Journal of Australia,2017,10.5694/mja17.00295,https://experts.mcmaster.ca/display/publication1460636,2025-07-27T15:10:54.978038
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome,Gastroenterology,2017,10.1053/j.gastro.2017.05.003,https://experts.mcmaster.ca/display/publication762782,2025-07-27T15:10:54.978039
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial",Canadian Journal of Cardiology,2017,10.1016/j.cjca.2017.06.001,https://experts.mcmaster.ca/display/publication1317907,2025-07-27T15:10:54.978040
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies,Gastroenterology,2017,10.1053/j.gastro.2017.04.009,https://experts.mcmaster.ca/display/publication178356,2025-07-27T15:10:54.978041
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,White Paper AGA: Functional Dyspepsia,Clinical Gastroenterology and Hepatology,2017,10.1016/j.cgh.2017.05.013,https://experts.mcmaster.ca/display/publication1040495,2025-07-27T15:10:54.978042
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,ACG and CAG Clinical Guideline: Management of Dyspepsia,American Journal of Gastroenterology,2017,10.1038/ajg.2017.154,https://experts.mcmaster.ca/display/publication1521472,2025-07-27T15:10:54.978043
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Antacids, sucralfate and bismuth salts for functional dyspepsia",Cochrane Database of Systematic Reviews,2017,10.1002/14651858.cd012686,https://experts.mcmaster.ca/display/publication1747268,2025-07-27T15:10:54.978044
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial,American Journal of Gastroenterology,2017,10.1038/ajg.2017.52,https://experts.mcmaster.ca/display/publication695508,2025-07-27T15:10:54.978045
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.,Canadian Family Physician,2017,,https://experts.mcmaster.ca/display/publication431902,2025-07-27T15:10:54.978046
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Déprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.,Canadian Family Physician,2017,,https://experts.mcmaster.ca/display/publication431901,2025-07-27T15:10:54.978047
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Editorial: latent class analysis to improve confidence in the diagnosis ofIBS– authors’ reply,Alimentary Pharmacology and Therapeutics,2017,10.1111/apt.14012,https://experts.mcmaster.ca/display/publication522575,2025-07-27T15:10:54.978048
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia,Scandinavian Journal of Gastroenterology,2017,10.1080/00365521.2016.1267792,https://experts.mcmaster.ca/display/publication522579,2025-07-27T15:10:54.978049
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Letter:NICEreferral criteria for lower gastrointestinal alarm features – not ideal but not poor either. Authors' reply,Alimentary Pharmacology and Therapeutics,2017,10.1111/apt.13996,https://experts.mcmaster.ca/display/publication522570,2025-07-27T15:10:54.978050
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Deprescribing versus continuation of chronic proton pump inhibitor use in adults,Cochrane Database of Systematic Reviews,2017,10.1002/14651858.cd011969.pub2,https://experts.mcmaster.ca/display/publication431903,2025-07-27T15:10:54.978051
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitors for functional dyspepsia,Cochrane Database of Systematic Reviews,2017,10.1002/14651858.cd011194.pub2,https://experts.mcmaster.ca/display/publication522560,2025-07-27T15:10:54.978052
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis,Alimentary Pharmacology and Therapeutics,2017,10.1111/apt.13949,https://experts.mcmaster.ca/display/publication522558,2025-07-27T15:10:54.978053
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis,Gut,2017,10.1136/gutjnl-2015-310721,https://experts.mcmaster.ca/display/publication695614,2025-07-27T15:10:54.978054
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Optimal strategies for pancreatic cyst surveillance: we need better comparative data, not more case series",Gastrointestinal Endoscopy,2017,10.1016/j.gie.2016.09.007,https://experts.mcmaster.ca/display/publication695527,2025-07-27T15:10:54.978055
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The gut microbiota and psychiatric illness,Journal of Psychiatry & Neuroscience,2017,10.1503/jpn.170028,https://experts.mcmaster.ca/display/publication176584,2025-07-27T15:10:54.978056
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 2,Polskie Archiwum Medycyny Wewnetrznej,2017,10.20452/pamw.3963,https://experts.mcmaster.ca/display/publication888675,2025-07-27T15:10:54.978057
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Microbiome: the beginning of understanding Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 1,Polskie Archiwum Medycyny Wewnetrznej,2017,10.20452/pamw.3961,https://experts.mcmaster.ca/display/publication888676,2025-07-27T15:10:54.978058
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease,Gastroenterology,2017,10.1053/j.gastro.2016.12.027,https://experts.mcmaster.ca/display/publication695510,2025-07-27T15:10:54.978059
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis,Endoscopy,2017,10.1055/s-0042-119035,https://experts.mcmaster.ca/display/publication684354,2025-07-27T15:10:54.978060
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report,Gut,2017,10.1136/gutjnl-2016-312288,https://experts.mcmaster.ca/display/publication695533,2025-07-27T15:10:54.978061
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis,Polskie Archiwum Medycyny Wewnetrznej,2017,10.20452/pamw.3963,https://experts.mcmaster.ca/display/publication695515,2025-07-27T15:10:54.978062
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Microbiome: the beginning of understanding,Polskie Archiwum Medycyny Wewnetrznej,2017,10.20452/pamw.3961,https://experts.mcmaster.ca/display/publication695525,2025-07-27T15:10:54.978063
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care,Alimentary Pharmacology and Therapeutics,2017,10.1111/apt.13846,https://experts.mcmaster.ca/display/publication522555,2025-07-27T15:10:54.978064
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2017,10.1053/j.gastro.2016.11.036,https://experts.mcmaster.ca/display/publication485168,2025-07-27T15:10:54.978065
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Feuerstein J et al. “Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005–2013) for Barrett’s Esophagus”. doi:10.1007/s10620-016-4222-2,Digestive Diseases and Sciences,2016,10.1007/s10620-016-4279-y,https://experts.mcmaster.ca/display/publication444385,2025-07-27T15:10:54.978066
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis,The Lancet Oncology,2016,10.1016/s1470-2045(16)30240-6,https://experts.mcmaster.ca/display/publication695531,2025-07-27T15:10:54.978067
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,An index with improved diagnostic accuracy for the diagnosis of Crohn's disease derived from the Lennard‐Jones criteria,Alimentary Pharmacology and Therapeutics,2016,10.1111/apt.13727,https://experts.mcmaster.ca/display/publication436496,2025-07-27T15:10:54.978068
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Fecal transplantation,Current Opinion in Gastroenterology,2016,10.1097/mog.0000000000000285,https://experts.mcmaster.ca/display/publication695606,2025-07-27T15:10:54.978069
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults,Gastroenterology,2016,10.1053/j.gastro.2016.04.006,https://experts.mcmaster.ca/display/publication485194,2025-07-27T15:10:54.978070
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis,Cochrane Database of Systematic Reviews,2016,10.1002/14651858.cd010571.pub2,https://experts.mcmaster.ca/display/publication684336,2025-07-27T15:10:54.978071
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The gut microbiome: Potential innovations for the understanding and treatment of psychopathology.,Canadian Psychology,2016,10.1037/cap0000038,https://experts.mcmaster.ca/display/publication209097,2025-07-27T15:10:54.978072
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication therapy for peptic ulcer disease inHelicobacter pylori-positive people,Cochrane Database of Systematic Reviews,2016,10.1002/14651858.cd003840.pub5,https://experts.mcmaster.ca/display/publication695588,2025-07-27T15:10:54.978073
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Antidepressants for Functional Dyspepsia: New Indications for Old Therapies?,Clinical Gastroenterology and Hepatology,2016,10.1016/j.cgh.2015.12.006,https://experts.mcmaster.ca/display/publication695616,2025-07-27T15:10:54.978074
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection,Journal of the American Medical Association (JAMA),2016,10.1001/jama.2015.18098,https://experts.mcmaster.ca/display/publication128052,2025-07-27T15:10:54.978075
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gluten Introduction to Infant Feeding and Risk of Celiac Disease: Systematic Review and Meta-Analysis,Journal of Pediatrics,2016,10.1016/j.jpeds.2015.09.032,https://experts.mcmaster.ca/display/publication522588,2025-07-27T15:10:54.978076
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Light Shines on: American Journal of Gastroenterology 2015,American Journal of Gastroenterology,2015,10.1038/ajg.2015.383,https://experts.mcmaster.ca/display/publication695571,2025-07-27T15:10:54.978077
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial",Trials,2015,10.1186/s13063-015-0826-7,https://experts.mcmaster.ca/display/publication695657,2025-07-27T15:10:54.978078
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Deprescribing versus continuation of chronic proton pump inhibitor use in adults,Clinical Respiratory Journal,2015,10.1002/14651858.cd011969,https://experts.mcmaster.ca/display/publication1747269,2025-07-27T15:10:54.978079
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Lost in Translation: The Gut Microbiota in Psychiatric Illness,Canadian Journal of Psychiatry,2015,10.1177/070674371506001007,https://experts.mcmaster.ca/display/publication176585,2025-07-27T15:10:54.978080
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial,Journal of Medical Screening,2015,10.1177/0969141315575052,https://experts.mcmaster.ca/display/publication695596,2025-07-27T15:10:54.978080
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2015,10.1053/j.gastro.2015.07.038,https://experts.mcmaster.ca/display/publication695578,2025-07-27T15:10:54.978081
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study",Gastroenterology,2015,10.1053/j.gastro.2015.04.020,https://experts.mcmaster.ca/display/publication695610,2025-07-27T15:10:54.978082
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review,Clinical and Translational Gastroenterology,2015,10.1038/ctg.2015.21,https://experts.mcmaster.ca/display/publication695602,2025-07-27T15:10:54.978083
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylorieradication for the prevention of gastric neoplasia,Clinical Respiratory Journal,2015,10.1002/14651858.cd005583.pub2,https://experts.mcmaster.ca/display/publication695598,2025-07-27T15:10:54.978084
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey,Scandinavian Journal of Gastroenterology,2015,10.3109/00365521.2015.1007079,https://experts.mcmaster.ca/display/publication522603,2025-07-27T15:10:54.978085
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency,American Journal of Gastroenterology,2015,10.1038/ajg.2015.128,https://experts.mcmaster.ca/display/publication522601,2025-07-27T15:10:54.978086
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial,Gastroenterology,2015,10.1053/j.gastro.2015.04.001,https://experts.mcmaster.ca/display/publication436556,2025-07-27T15:10:54.978087
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis",Gut,2015,10.1136/gutjnl-2014-307843,https://experts.mcmaster.ca/display/publication695315,2025-07-27T15:10:54.978088
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,No increase in prevalence of somatization in functionalvsorganic dyspepsia: a cross‐sectional survey,Neurogastroenterology and Motility,2015,10.1111/nmo.12578,https://experts.mcmaster.ca/display/publication522586,2025-07-27T15:10:54.978089
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia",American Journal of Gastroenterology,2015,10.1038/ajg.2015.151,https://experts.mcmaster.ca/display/publication929479,2025-07-27T15:10:54.978090
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (vol 110, pg 662, 2015)",American Journal of Gastroenterology,2015,10.1038/ajg.2015.151,https://experts.mcmaster.ca/display/publication444910,2025-07-27T15:10:54.978091
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Anti-inflammatory Intervention in Depression,JAMA psychiatry,2015,10.1001/jamapsychiatry.2014.3246,https://experts.mcmaster.ca/display/publication695693,2025-07-27T15:10:54.978092
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia",American Journal of Gastroenterology,2015,10.1038/ajg.2015.55,https://experts.mcmaster.ca/display/publication444920,2025-07-27T15:10:54.978093
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Lack of Utility of Symptoms and Signs at First Presentation as Predictors of Inflammatory Bowel Disease in Secondary Care,American Journal of Gastroenterology,2015,10.1038/ajg.2015.117,https://experts.mcmaster.ca/display/publication436550,2025-07-27T15:10:54.978094
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts,Gastroenterology,2015,10.1053/j.gastro.2015.01.015,https://experts.mcmaster.ca/display/publication695691,2025-07-27T15:10:54.978095
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,American Gastroenterological Association Technical Review on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts,Gastroenterology,2015,10.1053/j.gastro.2015.01.014,https://experts.mcmaster.ca/display/publication695659,2025-07-27T15:10:54.978096
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Management of Pancreatic Cysts in an Evidence-Based World,Gastroenterology,2015,10.1053/j.gastro.2015.02.035,https://experts.mcmaster.ca/display/publication626845,2025-07-27T15:10:54.978097
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating",Alimentary Pharmacology and Therapeutics,2015,10.1111/apt.13074,https://experts.mcmaster.ca/display/publication522585,2025-07-27T15:10:54.978098
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus,Gastroenterology,2015,10.1053/j.gastro.2014.10.041,https://experts.mcmaster.ca/display/publication245272,2025-07-27T15:10:54.978099
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Atreja et al.,American Journal of Gastroenterology,2015,10.1038/ajg.2014.377,https://experts.mcmaster.ca/display/publication684434,2025-07-27T15:10:54.978100
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pyloriInfection,BioMed Research International,2015,10.1155/2015/278308,https://experts.mcmaster.ca/display/publication1040558,2025-07-27T15:10:54.978101
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Tax-Deductible Provisions for Gluten-Free Diet in Canada Compared with Systems for Gluten-Free Diet Coverage Available in Various Countries,Canadian Journal of Gastroenterology and Hepatology,2015,10.1155/2015/508156,https://experts.mcmaster.ca/display/publication522602,2025-07-27T15:10:54.978102
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton Pump Inhibitors and Risk of Bone Fractures,Current Treatment Options in Gastroenterology,2014,10.1007/s11938-014-0030-y,https://experts.mcmaster.ca/display/publication1040514,2025-07-27T15:10:54.978103
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review: Fiber supplementation improves symptoms in the irritable bowel syndrome,ACP journal club,2014,10.7326/0003-4819-161-10-201411180-02010,https://experts.mcmaster.ca/display/publication1747276,2025-07-27T15:10:54.978104
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Bead study: a novel method to measure gastrointestinal transit in mice,Neurogastroenterology and Motility,2014,10.1111/nmo.12442,https://experts.mcmaster.ca/display/publication522591,2025-07-27T15:10:54.978105
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis",American Journal of Gastroenterology,2014,10.1038/ajg.2014.202,https://experts.mcmaster.ca/display/publication695217,2025-07-27T15:10:54.978106
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis",American Journal of Gastroenterology,2014,10.1038/ajg.2014.148,https://experts.mcmaster.ca/display/publication695213,2025-07-27T15:10:54.978107
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis,American Journal of Gastroenterology,2014,10.1038/ajg.2014.195,https://experts.mcmaster.ca/display/publication695189,2025-07-27T15:10:54.978108
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation,American Journal of Gastroenterology,2014,10.1038/ajg.2014.187,https://experts.mcmaster.ca/display/publication695232,2025-07-27T15:10:54.978109
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitors for functional dyspepsia,Clinical Respiratory Journal,2014,10.1002/14651858.cd011194,https://experts.mcmaster.ca/display/publication1734800,2025-07-27T15:10:54.978110
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2014,10.1038/ajg.2014.82,https://experts.mcmaster.ca/display/publication684438,2025-07-27T15:10:54.978111
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials,The BMJ,2014,10.1136/bmj.g3174,https://experts.mcmaster.ca/display/publication695120,2025-07-27T15:10:54.978112
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Whom should we ""test and treat"" for Helicobacter pylori?",The BMJ,2014,10.1136/bmj.g3320,https://experts.mcmaster.ca/display/publication1040516,2025-07-27T15:10:54.978113
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Whom should we ""test and treat"" for Helicobacter pylori?",The BMJ,2014,10.1136/bmj.g3320,https://experts.mcmaster.ca/display/publication695175,2025-07-27T15:10:54.978114
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review: Calprotectin testing differentiates inflammatory bowel disease from the irritable bowel syndrome,ACP journal club,2014,10.7326/0003-4819-160-8-201404150-02013,https://experts.mcmaster.ca/display/publication695667,2025-07-27T15:10:54.978115
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Rates of upper gastrointestinal endoscopy and gastro-oesophageal malignancy outcomes,Gut,2014,10.1136/gutjnl-2013-305635,https://experts.mcmaster.ca/display/publication694998,2025-07-27T15:10:54.978116
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Rome III Criteria for the Diagnosis of Functional Dyspepsia in Secondary Care Are Not Superior to Previous Definitions,Gastroenterology,2014,10.1053/j.gastro.2014.01.014,https://experts.mcmaster.ca/display/publication522639,2025-07-27T15:10:54.978117
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria,Alimentary Pharmacology and Therapeutics,2014,10.1111/apt.12573,https://experts.mcmaster.ca/display/publication522637,2025-07-27T15:10:54.978118
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply to Kawakami et al.,Endoscopy,2014,10.1055/s-0033-1358952,https://experts.mcmaster.ca/display/publication684428,2025-07-27T15:10:54.978119
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus,Gut,2014,10.1136/gutjnl-2013-305372,https://experts.mcmaster.ca/display/publication695305,2025-07-27T15:10:54.978120
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy,Canadian Journal of Gastroenterology and Hepatology,2014,10.1155/2014/346590,https://experts.mcmaster.ca/display/publication485248,2025-07-27T15:10:54.978121
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Optimum duration of regimens forHelicobacter pylorieradication,Cochrane Database of Systematic Reviews,2013,10.1002/14651858.cd008337.pub2,https://experts.mcmaster.ca/display/publication684443,2025-07-27T15:10:54.978123
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Randomized controlled trial comparing telephone and mail follow-up for recruitment of participants into a clinical trial of colorectal cancer screening,Trials,2013,10.1186/1745-6215-14-40,https://experts.mcmaster.ca/display/publication695090,2025-07-27T15:10:54.978124
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care,Gastroenterology,2013,10.1053/j.gastro.2013.08.048,https://experts.mcmaster.ca/display/publication522625,2025-07-27T15:10:54.978125
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Crohn disease was not associated with increased risk for mortality,ACP journal club,2013,10.7326/0003-4819-159-10-201311190-02012,https://experts.mcmaster.ca/display/publication695050,2025-07-27T15:10:54.978126
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Dyspepsia,Current Opinion in Gastroenterology,2013,10.1097/mog.0b013e328365d45d,https://experts.mcmaster.ca/display/publication695100,2025-07-27T15:10:54.978127
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The authors reply,Critical Care Medicine,2013,10.1097/ccm.0b013e3182a42e5d,https://experts.mcmaster.ca/display/publication211554,2025-07-27T15:10:54.978128
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gamma-amino butyric acid (GABA) receptor agonists for gastroesophageal reflux disease (GERD),Clinical Respiratory Journal,2013,10.1002/14651858.cd008912.pub2,https://experts.mcmaster.ca/display/publication1709554,2025-07-27T15:10:54.978129
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian association of gastroenterology position statement: Hip fracture and proton pump inhibitor therapy -a 2013 update,Canadian Journal of Gastroenterology,2013,,https://experts.mcmaster.ca/display/publication1747287,2025-07-27T15:10:54.978130
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Nahon et al. and Marmo et al.,American Journal of Gastroenterology,2013,10.1038/ajg.2013.195,https://experts.mcmaster.ca/display/publication695075,2025-07-27T15:10:54.978131
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Dyspepsia,The BMJ,2013,10.1136/bmj.f5059,https://experts.mcmaster.ca/display/publication695103,2025-07-27T15:10:54.978132
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Dyspepsia.,The BMJ,2013,10.1136/bmj.f5059,https://experts.mcmaster.ca/display/publication1040517,2025-07-27T15:10:54.978133
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis,Endoscopy,2013,10.1055/s-0032-1326640,https://experts.mcmaster.ca/display/publication684440,2025-07-27T15:10:54.978134
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitis,Clinical Respiratory Journal,2013,10.1002/14651858.cd010581,https://experts.mcmaster.ca/display/publication1734792,2025-07-27T15:10:54.978135
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP),Clinical Respiratory Journal,2013,10.1002/14651858.cd010571,https://experts.mcmaster.ca/display/publication1734791,2025-07-27T15:10:54.978136
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Assessing the Value of Symptom Relief for Patients with Gastroesophageal Reflux Disease Treatment: Willingness to Pay Using a Discrete Choice Experiment,Value in Health,2013,10.1016/j.jval.2013.01.007,https://experts.mcmaster.ca/display/publication319250,2025-07-27T15:10:54.978137
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Management of reflux-related symptoms,Best Practice and Research in Clinical Gastroenterology,2013,10.1016/j.bpg.2013.06.004,https://experts.mcmaster.ca/display/publication695079,2025-07-27T15:10:54.978138
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux disease,Cochrane Database of Systematic Reviews,2013,10.1002/14651858.cd010499,https://experts.mcmaster.ca/display/publication1746861,2025-07-27T15:10:54.978139
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care,Alimentary Pharmacology and Therapeutics,2013,10.1111/apt.12254,https://experts.mcmaster.ca/display/publication695004,2025-07-27T15:10:54.978140
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effect of Comorbidity on Mortality in Patients With Peptic Ulcer Bleeding: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2013,10.1038/ajg.2012.451,https://experts.mcmaster.ca/display/publication695080,2025-07-27T15:10:54.978141
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection in functional dyspepsia,Nature Reviews Gastroenterology and Hepatology,2013,10.1038/nrgastro.2013.9,https://experts.mcmaster.ca/display/publication695167,2025-07-27T15:10:54.978143
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients,Critical Care Medicine,2013,10.1097/ccm.0b013e3182758734,https://experts.mcmaster.ca/display/publication211579,2025-07-27T15:10:54.978144
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial,CANADIAN MEDICAL ASSOCIATION JOURNAL,2013,10.1503/cmaj.120095,https://experts.mcmaster.ca/display/publication694984,2025-07-27T15:10:54.978145
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Peripheral Mechanisms in Irritable Bowel Syndrome,New England Journal of Medicine,2013,10.1056/nejmc1214185,https://experts.mcmaster.ca/display/publication695083,2025-07-27T15:10:54.978146
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Peripheral mechanisms in irritable bowel syndrome.,New England Journal of Medicine,2013,10.1056/NEJMc1214185,https://experts.mcmaster.ca/display/publication1510924,2025-07-27T15:10:54.978147
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Peripheral mechanisms in irritable bowel syndrome.,New England Journal of Medicine,2013,10.1056/NEJMc1214185,https://experts.mcmaster.ca/display/publication1510926,2025-07-27T15:10:54.978147
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Peripheral mechanisms in irritable bowel syndrome.,New England Journal of Medicine,2013,10.1056/NEJMc1214185,https://experts.mcmaster.ca/display/publication862963,2025-07-27T15:10:54.978149
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Ulcerative colitis,The BMJ,2013,10.1136/bmj.f432,https://experts.mcmaster.ca/display/publication495328,2025-07-27T15:10:54.978150
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Ulcerative colitis.,The BMJ,2013,10.1136/bmj.f432,https://experts.mcmaster.ca/display/publication1040518,2025-07-27T15:10:54.978151
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Stoking the Flame: The American Journal of Gastroenterology 2013,American Journal of Gastroenterology,2013,10.1038/ajg.2012.462,https://experts.mcmaster.ca/display/publication695669,2025-07-27T15:10:54.978152
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The natural history of gastro‐oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10‐year follow‐up study,Alimentary Pharmacology and Therapeutics,2013,10.1111/apt.12169,https://experts.mcmaster.ca/display/publication695101,2025-07-27T15:10:54.978153
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Acid-Suppressive Therapy With Esomeprazole for Relief of Unexplained Chest Pain in Primary Care: A Randomized, Double-Blind, Placebo-Controlled Trial",American Journal of Gastroenterology,2013,10.1038/ajg.2012.369,https://experts.mcmaster.ca/display/publication695160,2025-07-27T15:10:54.978154
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Association of Gastroenterology Position Statement: Hip Fracture and Proton Pump Inhibitor Therapy – a 2013 Update,Canadian Journal of Gastroenterology and Hepatology,2013,10.1155/2013/321379,https://experts.mcmaster.ca/display/publication694986,2025-07-27T15:10:54.978155
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis,Cochrane Database of Systematic Reviews,2012,10.1002/14651858.cd009662.pub2,https://experts.mcmaster.ca/display/publication684449,2025-07-27T15:10:54.978156
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit,Histopathology,2012,10.1111/j.1365-2559.2012.04288.x,https://experts.mcmaster.ca/display/publication695381,2025-07-27T15:10:54.978157
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Dyspepsia,Current Opinion in Gastroenterology,2012,10.1097/mog.0b013e328358ad9b,https://experts.mcmaster.ca/display/publication695105,2025-07-27T15:10:54.978158
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus,Nature Genetics,2012,10.1038/ng.2408,https://experts.mcmaster.ca/display/publication264554,2025-07-27T15:10:54.978159
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process",Gastroenterology,2012,10.1053/j.gastro.2012.04.032,https://experts.mcmaster.ca/display/publication273960,2025-07-27T15:10:54.978160
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review article: current treatment options and management of functional dyspepsia,Alimentary Pharmacology and Therapeutics,2012,10.1111/j.1365-2036.2012.05128.x,https://experts.mcmaster.ca/display/publication695276,2025-07-27T15:10:54.978161
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines,ACP journal club,2012,10.7326/0003-4819-156-11-201206050-00008,https://experts.mcmaster.ca/display/publication695076,2025-07-27T15:10:54.978162
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effect of Dyspepsia on Survival: A Longitudinal 10-Year Follow-Up Study,American Journal of Gastroenterology,2012,10.1038/ajg.2012.69,https://experts.mcmaster.ca/display/publication695190,2025-07-27T15:10:54.978163
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis,Clinical Gastroenterology and Hepatology,2012,10.1016/j.cgh.2011.10.043,https://experts.mcmaster.ca/display/publication695192,2025-07-27T15:10:54.978164
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics",Contemporary Clinical Trials,2012,10.1016/j.cct.2012.02.002,https://experts.mcmaster.ca/display/publication695278,2025-07-27T15:10:54.978165
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Iron Overload in Human Disease,New England Journal of Medicine,2012,10.1056/nejmc1202105,https://experts.mcmaster.ca/display/publication695653,2025-07-27T15:10:54.978166
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Does aspirin really reduce the risk of colon cancer?,The Lancet,2012,10.1016/s0140-6736(12)60672-2,https://experts.mcmaster.ca/display/publication695697,2025-07-27T15:10:54.978167
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding,Clinical Gastroenterology and Hepatology,2012,10.1016/j.cgh.2011.07.025,https://experts.mcmaster.ca/display/publication485375,2025-07-27T15:10:54.978168
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Doherty and Moss,American Journal of Gastroenterology,2012,10.1038/ajg.2011.455,https://experts.mcmaster.ca/display/publication695673,2025-07-27T15:10:54.978169
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The risks of PPI therapy,Nature Reviews Gastroenterology and Hepatology,2012,10.1038/nrgastro.2011.272,https://experts.mcmaster.ca/display/publication695067,2025-07-27T15:10:54.978170
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Stress ulcer prophylaxis in critically ill patients: review of the evidence,Polskie Archiwum Medycyny Wewnetrznej,2012,10.20452/pamw.1173,https://experts.mcmaster.ca/display/publication695176,2025-07-27T15:10:54.978171
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis",American Journal of Gastroenterology,2012,10.1038/ajg.2011.410,https://experts.mcmaster.ca/display/publication695161,2025-07-27T15:10:54.978172
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Kayhan et al.,American Journal of Gastroenterology,2012,10.1038/ajg.2011.382,https://experts.mcmaster.ca/display/publication695689,2025-07-27T15:10:54.978173
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature,PLoS ONE,2012,10.1371/journal.pone.0049163,https://experts.mcmaster.ca/display/publication695274,2025-07-27T15:10:54.978174
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.296,https://experts.mcmaster.ca/display/publication695168,2025-07-27T15:10:54.978175
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori Eradication for Functional Dyspepsia: What Are We Treating?,JAMA Internal Medicine,2011,10.1001/archinternmed.2011.541,https://experts.mcmaster.ca/display/publication695661,2025-07-27T15:10:54.978176
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on ""Helicobacter pylori eradication in functional dyspepsia"".",Archives of Internal Medicine,2011,10.1001/archinternmed.2011.541,https://experts.mcmaster.ca/display/publication1040519,2025-07-27T15:10:54.978177
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Atreja et al.,American Journal of Gastroenterology,2011,10.1038/ajg.2011.274,https://experts.mcmaster.ca/display/publication695687,2025-07-27T15:10:54.978178
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Yang et al.,American Journal of Gastroenterology,2011,10.1038/ajg.2011.246,https://experts.mcmaster.ca/display/publication695671,2025-07-27T15:10:54.978179
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply to Akobeng,American Journal of Gastroenterology,2011,10.1038/ajg.2011.218,https://experts.mcmaster.ca/display/publication695699,2025-07-27T15:10:54.978180
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile,Inflammatory Bowel Diseases,2011,10.1002/ibd.21514,https://experts.mcmaster.ca/display/publication695114,2025-07-27T15:10:54.978181
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Aspirin in the prevention of cancer,The Lancet,2011,10.1016/s0140-6736(11)60666-1,https://experts.mcmaster.ca/display/publication695726,2025-07-27T15:10:54.978182
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Corrigendum: Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.131,https://experts.mcmaster.ca/display/publication485397,2025-07-27T15:10:54.978183
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease,American Journal of Gastroenterology,2011,10.1038/ajg.2011.58,https://experts.mcmaster.ca/display/publication695215,2025-07-27T15:10:54.978184
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.72,https://experts.mcmaster.ca/display/publication485399,2025-07-27T15:10:54.978185
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.71,https://experts.mcmaster.ca/display/publication485415,2025-07-27T15:10:54.978186
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.67,https://experts.mcmaster.ca/display/publication485423,2025-07-27T15:10:54.978187
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.73,https://experts.mcmaster.ca/display/publication695385,2025-07-27T15:10:54.978189
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.64,https://experts.mcmaster.ca/display/publication695377,2025-07-27T15:10:54.978190
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2011.70,https://experts.mcmaster.ca/display/publication485427,2025-07-27T15:10:54.978191
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2011,10.1038/ajg.2010.317,https://experts.mcmaster.ca/display/publication695375,2025-07-27T15:10:54.978192
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: the More Things Change, the More They Stay the Same",Gastroenterology Clinics of North America,2011,10.1016/j.gtc.2010.12.007,https://experts.mcmaster.ca/display/publication695113,2025-07-27T15:10:54.978193
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication of Helicobacter pylori for non-ulcer dyspepsia,Cochrane Database of Systematic Reviews,2011,10.1002/14651858.cd002096.pub5,https://experts.mcmaster.ca/display/publication446202,2025-07-27T15:10:54.978194
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Medical treatments in the short term management of reflux oesophagitis,Cochrane Database of Systematic Reviews,2011,10.1002/14651858.cd003244.pub3,https://experts.mcmaster.ca/display/publication695058,2025-07-27T15:10:54.978195
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pharmacological interventions for non-ulcer dyspepsia,Clinical Respiratory Journal,2011,10.1002/14651858.cd001960.pub4,https://experts.mcmaster.ca/display/publication695045,2025-07-27T15:10:54.978196
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychological interventions for non-ulcer dyspepsia,Cochrane Database of Systematic Reviews,2011,10.1002/14651858.cd002301.pub5,https://experts.mcmaster.ca/display/publication695078,2025-07-27T15:10:54.978197
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2011,10.1053/j.gastro.2010.12.031,https://experts.mcmaster.ca/display/publication1941929,2025-07-27T15:10:54.978198
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Does long term aspirin prevent cancer?,The BMJ,2010,10.1136/bmj.c7326,https://experts.mcmaster.ca/display/publication695109,2025-07-27T15:10:54.978199
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire,Internal and emergency medicine,2010,10.1007/s11739-010-0467-5,https://experts.mcmaster.ca/display/publication695280,2025-07-27T15:10:54.978200
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial,American Journal of Gastroenterology,2010,10.1038/ajg.2010.368,https://experts.mcmaster.ca/display/publication695081,2025-07-27T15:10:54.978201
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis,Clinical Gastroenterology and Hepatology,2010,10.1016/j.cgh.2010.05.031,https://experts.mcmaster.ca/display/publication458945,2025-07-27T15:10:54.978202
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Cappell,American Journal of Gastroenterology,2010,10.1038/ajg.2010.222,https://experts.mcmaster.ca/display/publication695764,2025-07-27T15:10:54.978203
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding,Cochrane Database of Systematic Reviews,2010,10.1002/14651858.cd005415.pub3,https://experts.mcmaster.ca/display/publication695077,2025-07-27T15:10:54.978204
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome,Alimentary Pharmacology and Therapeutics,2010,10.1111/j.1365-2036.2010.04328.x,https://experts.mcmaster.ca/display/publication695104,2025-07-27T15:10:54.978205
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Cost‐utility analysis of proton pump inhibitors and other gastro‐protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti‐inflammatory agents,Alimentary Pharmacology and Therapeutics,2010,10.1111/j.1365-2036.2010.04305.x,https://experts.mcmaster.ca/display/publication695110,2025-07-27T15:10:54.978206
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery,Gut,2010,10.1136/gut.2009.202234,https://experts.mcmaster.ca/display/publication485499,2025-07-27T15:10:54.978207
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Prevalence of Uninvestigated Dyspepsia 8 Years After a Large Waterborne Outbreak of Bacterial Dysentery: A Cohort Study,Gastroenterology,2010,10.1053/j.gastro.2010.01.043,https://experts.mcmaster.ca/display/publication485474,2025-07-27T15:10:54.978208
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia,Clinical Gastroenterology and Hepatology,2010,10.1016/j.cgh.2009.07.020,https://experts.mcmaster.ca/display/publication458960,2025-07-27T15:10:54.978209
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis,Gastroenterology,2010,10.1053/j.gastro.2009.12.049,https://experts.mcmaster.ca/display/publication485501,2025-07-27T15:10:54.978210
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Methodology for Randomized Trials of Patients With Nonvariceal Upper Gastrointestinal Bleeding: Recommendations From an International Consensus Conference,American Journal of Gastroenterology,2010,10.1038/ajg.2009.702,https://experts.mcmaster.ca/display/publication695282,2025-07-27T15:10:54.978211
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review,Gut,2010,10.1136/gut.2008.167270,https://experts.mcmaster.ca/display/publication695359,2025-07-27T15:10:54.978212
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,“Power” of Selective Serotonin Reuptake Inhibitors in Irritable Bowel Syndrome,Clinical Gastroenterology and Hepatology,2010,10.1016/j.cgh.2009.10.027,https://experts.mcmaster.ca/display/publication695046,2025-07-27T15:10:54.978213
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease,Cochrane Database of Systematic Reviews,2010,10.1002/14651858.cd003245.pub3,https://experts.mcmaster.ca/display/publication694990,2025-07-27T15:10:54.978215
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Errors in the Conduct of Systematic Reviews of Pharmacological Interventions for Irritable Bowel Syndrome,American Journal of Gastroenterology,2010,10.1038/ajg.2009.658,https://experts.mcmaster.ca/display/publication695361,2025-07-27T15:10:54.978216
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The American College of Gastroenterology Irritable Bowel Syndrome Monograph: Translating Systematic Review Data to Clinical Practice,Gastroenterology,2010,10.1053/j.gastro.2009.09.077,https://experts.mcmaster.ca/display/publication695287,2025-07-27T15:10:54.978217
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding,ACP journal club,2010,10.7326/0003-4819-152-2-201001190-00009,https://experts.mcmaster.ca/display/publication695207,2025-07-27T15:10:54.978218
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability,American Journal of Gastroenterology,2010,10.1038/ajg.2009.508,https://experts.mcmaster.ca/display/publication695062,2025-07-27T15:10:54.978219
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Passing the Torch: The American Journal of Gastroenterology 2010,American Journal of Gastroenterology,2010,10.1038/ajg.2009.710,https://experts.mcmaster.ca/display/publication695916,2025-07-27T15:10:54.978219
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Sequential Therapy for Eradication of Helicobacter pylori: A New Guiding Light or a False Dawn?,American Journal of Gastroenterology,2009,10.1038/ajg.2009.563,https://experts.mcmaster.ca/display/publication694974,2025-07-27T15:10:54.978220
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis,Clinical Gastroenterology and Hepatology,2009,10.1016/j.cgh.2009.06.031,https://experts.mcmaster.ca/display/publication695363,2025-07-27T15:10:54.978221
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial management strategies for dyspepsia,Clinical Respiratory Journal,2009,10.1002/14651858.cd001961.pub3,https://experts.mcmaster.ca/display/publication695087,2025-07-27T15:10:54.978222
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Redundant Data in the Meta-analysis onHelicobacter pyloriEradication,ACP journal club,2009,10.7326/0003-4819-151-7-200910060-00014,https://experts.mcmaster.ca/display/publication695888,2025-07-27T15:10:54.978223
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials",Diseases of the Colon and Rectum,2009,10.1007/dcr.0b013e3181ae0ab8,https://experts.mcmaster.ca/display/publication695224,2025-07-27T15:10:54.978224
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,American Family Physician,2009,,https://experts.mcmaster.ca/display/publication695194,2025-07-27T15:10:54.978225
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Bran's deleterious effects: much ado about nothing,The BMJ,2009,10.1136/bmj.b3956,https://experts.mcmaster.ca/display/publication694996,2025-07-27T15:10:54.978226
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Is it safe to use a proton pump inhibitor with clopidogrel?,Polskie Archiwum Medycyny Wewnetrznej,2009,10.20452/pamw.767,https://experts.mcmaster.ca/display/publication695180,2025-07-27T15:10:54.978227
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Managing dyspepsia,Current Gastroenterology Reports,2009,10.1007/s11894-009-0042-2,https://experts.mcmaster.ca/display/publication1040520,2025-07-27T15:10:54.978228
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Treatment of chronic gastro-oesophageal reflux disease,The BMJ,2009,10.1136/bmj.b2481,https://experts.mcmaster.ca/display/publication695052,2025-07-27T15:10:54.978229
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,10‐biomarker algorithm to identify irritable bowel syndrome,Alimentary Pharmacology and Therapeutics,2009,10.1111/j.1365-2036.2009.04007.x,https://experts.mcmaster.ca/display/publication695164,2025-07-27T15:10:54.978230
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Alarm features of colorectal cancer Reply,Gut,2009,,https://experts.mcmaster.ca/display/publication695914,2025-07-27T15:10:54.978231
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Authors' reply,Gut,2009,,https://experts.mcmaster.ca/display/publication1747286,2025-07-27T15:10:54.978232
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2009,10.1038/ajg.2009.223,https://experts.mcmaster.ca/display/publication695124,2025-07-27T15:10:54.978233
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Meta‐analysis: yield of diagnostic tests for coeliac disease in dyspepsia,Alimentary Pharmacology and Therapeutics,2009,10.1111/j.1365-2036.2009.04008.x,https://experts.mcmaster.ca/display/publication695165,2025-07-27T15:10:54.978234
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?,Polskie Archiwum Medycyny Wewnetrznej,2009,10.20452/pamw.717,https://experts.mcmaster.ca/display/publication695220,2025-07-27T15:10:54.978235
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms? (vol 300, pg 1793, 2008)",Journal of the American Medical Association (JAMA),2009,,https://experts.mcmaster.ca/display/publication695908,2025-07-27T15:10:54.978236
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Yield of Diagnostic Tests for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome,JAMA Internal Medicine,2009,10.1001/archinternmed.2009.22,https://experts.mcmaster.ca/display/publication695868,2025-07-27T15:10:54.978237
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome (vol 104, pg S1, 2009)",American Journal of Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695902,2025-07-27T15:10:54.978238
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Testing for Celiac Disease in Patients With Symptoms of Irritable Bowel Syndrome—Reply,Journal of the American Medical Association (JAMA),2009,10.1001/jama.2009.273,https://experts.mcmaster.ca/display/publication695874,2025-07-27T15:10:54.978239
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks,Alimentary Pharmacology and Therapeutics,2009,10.1111/j.1365-2036.2008.03905.x,https://experts.mcmaster.ca/display/publication695106,2025-07-27T15:10:54.978240
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis,Gut,2009,10.1136/gut.2008.163162,https://experts.mcmaster.ca/display/publication695387,2025-07-27T15:10:54.978241
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,GERD in Adults,American Family Physician,2009,,https://experts.mcmaster.ca/display/publication695894,2025-07-27T15:10:54.978242
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome,American Journal of Gastroenterology,2009,10.1038/ajg.2008.122,https://experts.mcmaster.ca/display/publication695910,2025-07-27T15:10:54.978243
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Diagnosis and Management of Non-Erosive Reflux Disease – The Vevey NERD Consensus Group,Digestion,2009,10.1159/000219365,https://experts.mcmaster.ca/display/publication695295,2025-07-27T15:10:54.978244
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?,Canadian Journal of Gastroenterology and Hepatology,2009,10.1155/2009/868946,https://experts.mcmaster.ca/display/publication695084,2025-07-27T15:10:54.978245
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,CON: Evidence-Based Medicine-The Emperor's New Clothes?,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2008.02193_3.x,https://experts.mcmaster.ca/display/publication695064,2025-07-27T15:10:54.978246
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pro: EBM: an invaluable tool for medical practice.,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2008.02193_2.x,https://experts.mcmaster.ca/display/publication1747283,2025-07-27T15:10:54.978247
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis",The BMJ,2008,10.1136/bmj.a2313,https://experts.mcmaster.ca/display/publication695355,2025-07-27T15:10:54.978248
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis,Gut,2008,10.1136/gut.2008.159723,https://experts.mcmaster.ca/display/publication695307,2025-07-27T15:10:54.978249
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Optimizing Surveillance in Barrett's Esophagus: Response to Ruggeet al.,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2008.02094_10.x,https://experts.mcmaster.ca/display/publication695396,2025-07-27T15:10:54.978250
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient's Lower Gastrointestinal Tract Symptoms?,Journal of the American Medical Association (JAMA),2008,10.1001/jama.300.15.1793,https://experts.mcmaster.ca/display/publication695369,2025-07-27T15:10:54.978251
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Fluctuation of gastrointestinal symptoms in the community: a 10‐year longitudinal follow‐up study,Alimentary Pharmacology and Therapeutics,2008,10.1111/j.1365-2036.2008.03813.x,https://experts.mcmaster.ca/display/publication695122,2025-07-27T15:10:54.978252
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2008.02031.x,https://experts.mcmaster.ca/display/publication695053,2025-07-27T15:10:54.978253
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response:,Gastrointestinal Endoscopy,2008,10.1016/j.gie.2008.05.007,https://experts.mcmaster.ca/display/publication684350,2025-07-27T15:10:54.978254
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Meta‐analysis:Helicobacter pylori‘test and treat’ compared with empirical acid suppression for managing dyspepsia,Alimentary Pharmacology and Therapeutics,2008,10.1111/j.1365-2036.2008.03784.x,https://experts.mcmaster.ca/display/publication695299,2025-07-27T15:10:54.978255
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview,Digestive Diseases and Sciences,2008,10.1007/s10620-008-0410-z,https://experts.mcmaster.ca/display/publication695049,2025-07-27T15:10:54.978256
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Clinical trial design in adult reflux disease: a methodological workshop,Alimentary Pharmacology and Therapeutics,2008,10.1111/j.1365-2036.2008.03700.x,https://experts.mcmaster.ca/display/publication695270,2025-07-27T15:10:54.978257
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,GORD in adults.,Clinical Evidence,2008,,https://experts.mcmaster.ca/display/publication1040544,2025-07-27T15:10:54.978258
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2007.01740.x,https://experts.mcmaster.ca/display/publication695199,2025-07-27T15:10:54.978259
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2008.01790.x,https://experts.mcmaster.ca/display/publication695367,2025-07-27T15:10:54.978260
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Mortality risks associated with Barrett’s oesophagus: authors' reply,Alimentary Pharmacology and Therapeutics,2008,10.1111/j.1365-2036.2008.03651.x,https://experts.mcmaster.ca/display/publication695409,2025-07-27T15:10:54.978261
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pyloritest and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial),The BMJ,2008,10.1136/bmj.39479.640486.ae,https://experts.mcmaster.ca/display/publication695343,2025-07-27T15:10:54.978262
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Asia–Pacific consensus guidelines on gastric cancer prevention,Journal of Gastroenterology and Hepatology,2008,10.1111/j.1440-1746.2008.05314.x,https://experts.mcmaster.ca/display/publication695357,2025-07-27T15:10:54.978263
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastric Cancer Consensus Conference RecommendsHelicobacter pyloriScreening and Treatment in Asymptomatic Persons From High-Risk Populations to Prevent Gastric Cancer,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2008.01819.x,https://experts.mcmaster.ca/display/publication695158,2025-07-27T15:10:54.978264
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Barrett's Esophagus and Obesity: The Missing Part of the Puzzle,American Journal of Gastroenterology,2008,10.1111/j.1572-0241.2007.01618.x,https://experts.mcmaster.ca/display/publication694961,2025-07-27T15:10:54.978265
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,EUS: a meta-analysis of test performance in suspected choledocholithiasis,Gastrointestinal Endoscopy,2008,10.1016/j.gie.2007.09.047,https://experts.mcmaster.ca/display/publication684372,2025-07-27T15:10:54.978266
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Mortality rates in patients with Barrett’s oesophagus,Alimentary Pharmacology and Therapeutics,2008,10.1111/j.1365-2036.2007.03582.x,https://experts.mcmaster.ca/display/publication660175,2025-07-27T15:10:54.978267
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States,Medical decision making,2008,10.1177/0272989x07309644,https://experts.mcmaster.ca/display/publication695345,2025-07-27T15:10:54.978268
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis,World Journal of Gastroenterology,2008,10.3748/wjg.14.7361,https://experts.mcmaster.ca/display/publication695226,2025-07-27T15:10:54.978269
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Current Guidelines for Dyspepsia Management,Digestive Diseases,2008,10.1159/000121351,https://experts.mcmaster.ca/display/publication695173,2025-07-27T15:10:54.978269
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Hip Fracture and Proton Pump Inhibitor Therapy: Position Statement,Canadian Journal of Gastroenterology and Hepatology,2008,10.1155/2008/284165,https://experts.mcmaster.ca/display/publication695407,2025-07-27T15:10:54.978270
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,La Fracture de la Hanche et la Thérapie par Inhibiteurs de la Pompe à Protons : Un Document de Principes,Canadian Journal of Gastroenterology and Hepatology,2008,10.1155/2008/189531,https://experts.mcmaster.ca/display/publication1466936,2025-07-27T15:10:54.978271
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study,International Journal of Epidemiology,2007,10.1093/ije/dym201,https://experts.mcmaster.ca/display/publication695293,2025-07-27T15:10:54.978272
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding,Health Technology Assessment,2007,10.3310/hta11510,https://experts.mcmaster.ca/display/publication1040547,2025-07-27T15:10:54.978273
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding,Health Technology Assessment,2007,10.3310/hta11510,https://experts.mcmaster.ca/display/publication695118,2025-07-27T15:10:54.978274
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Clinical trial: knowledge of negativeHelicobacter pyloristatus reduces subsequent dyspepsia‐related resource use,Alimentary Pharmacology and Therapeutics,2007,10.1111/j.1365-2036.2007.03500.x,https://experts.mcmaster.ca/display/publication695209,2025-07-27T15:10:54.978275
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Die Montreal-Definition und -Klassifikation der gastroösophagealen Refluxkrankheit: Ein globales evidenzbasiertes Konsensus-Papier,Zeitschrift für Gastroenterologie,2007,10.1055/s-2007-963633,https://experts.mcmaster.ca/display/publication1746957,2025-07-27T15:10:54.978276
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Should triple therapy for Helicobacter pylori eradication be prescribed for 1 week or 2 weeks?,Nature Reviews Gastroenterology and Hepatology,2007,10.1038/ncpgasthep0956,https://experts.mcmaster.ca/display/publication694994,2025-07-27T15:10:54.978277
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Detection of Intestinal Metaplasia in Barrett's Esophagus,American Journal of Gastroenterology,2007,10.1111/j.1572-0241.2007.01353_6.x,https://experts.mcmaster.ca/display/publication206212,2025-07-27T15:10:54.978278
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Sequential regimens for Helicobacter pylori eradication,The Lancet,2007,10.1016/s0140-6736(07)61455-x,https://experts.mcmaster.ca/display/publication695060,2025-07-27T15:10:54.978279
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression,American Journal of Gastroenterology,2007,10.1111/j.1572-0241.2007.01275.x,https://experts.mcmaster.ca/display/publication485049,2025-07-27T15:10:54.978281
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Colorectal cancer screening lacks evidence of benefit.,Cleveland Clinic Journal of Medicine,2007,10.3949/ccjm.74.8.545,https://experts.mcmaster.ca/display/publication695398,2025-07-27T15:10:54.978282
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report,Gut,2007,10.1136/gut.2006.101634,https://experts.mcmaster.ca/display/publication1466933,2025-07-27T15:10:54.978283
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies,American Journal of Gastroenterology,2007,10.1111/j.1572-0241.2007.01230.x,https://experts.mcmaster.ca/display/publication198028,2025-07-27T15:10:54.978284
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review: eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H pylori infection,BMJ Evidence-Based Medicine,2007,10.1136/ebm.12.3.84,https://experts.mcmaster.ca/display/publication1040550,2025-07-27T15:10:54.978285
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review: Eradication therapy supplemented by probiotics increased eradication rates and reduced side effects inH. pyloriinfection,ACP journal club,2007,10.7326/acpjc-2007-146-3-063,https://experts.mcmaster.ca/display/publication1040552,2025-07-27T15:10:54.978286
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Who Consults With Dyspepsia? Results from a Longitudinal 10-Yr Follow-Up Study,American Journal of Gastroenterology,2007,10.1111/j.1572-0241.2007.01080.x,https://experts.mcmaster.ca/display/publication695309,2025-07-27T15:10:54.978287
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Medical treatments in the short term management of reflux oesophagitis,Clinical Respiratory Journal,2007,10.1002/14651858.cd003244.pub2,https://experts.mcmaster.ca/display/publication694955,2025-07-27T15:10:54.978288
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The health economics of Helicobacter pylori infection,Best Practice and Research in Clinical Gastroenterology,2007,10.1016/j.bpg.2006.11.004,https://experts.mcmaster.ca/display/publication695054,2025-07-27T15:10:54.978289
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study,Gut,2007,10.1136/gut.2006.099846,https://experts.mcmaster.ca/display/publication695179,2025-07-27T15:10:54.978290
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,International Comparisons of Manpower in Gastroenterology,American Journal of Gastroenterology,2007,10.1111/j.1572-0241.2006.00973.x,https://experts.mcmaster.ca/display/publication695222,2025-07-27T15:10:54.978291
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Short‐Form Leeds Dyspepsia Questionnaire validation study,Alimentary Pharmacology and Therapeutics,2007,10.1111/j.1365-2036.2006.03233.x,https://experts.mcmaster.ca/display/publication695351,2025-07-27T15:10:54.978292
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A European view of diagnostic yield and appropriateness of colonoscopy.,Hepato-Gastroenterology: current medical and surgical trends,2007,,https://experts.mcmaster.ca/display/publication1747297,2025-07-27T15:10:54.978293
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Recommendations on Chronic Constipation (including Constipation Associated with Irritable Bowel Syndrome) Treatment,Canadian Journal of Gastroenterology and Hepatology,2007,10.1155/2007/625783,https://experts.mcmaster.ca/display/publication862990,2025-07-27T15:10:54.978294
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Promises and Perils of Nurse-Led Flexible Sigmoidoscopy Screening,Canadian Journal of Gastroenterology and Hepatology,2007,10.1155/2007/238687,https://experts.mcmaster.ca/display/publication695457,2025-07-27T15:10:54.978295
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Variations in colonoscopy practice in Europe: A multicentre descriptive study (EPAGE),Scandinavian Journal of Gastroenterology,2007,10.1080/00365520600815647,https://experts.mcmaster.ca/display/publication1747288,2025-07-27T15:10:54.978296
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Who Provides Gastrointestinal Endoscopy in Canada?,Canadian Journal of Gastroenterology and Hepatology,2007,10.1155/2007/563895,https://experts.mcmaster.ca/display/publication695166,2025-07-27T15:10:54.978297
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Endoscopic therapy for patients with gastro-esophageal reflux disease (GORD),Cochrane Database of Systematic Reviews,2006,10.1002/14651858.cd006284,https://experts.mcmaster.ca/display/publication1747284,2025-07-27T15:10:54.978298
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms,Thorax,2006,10.1136/thx.2006.060087,https://experts.mcmaster.ca/display/publication695301,2025-07-27T15:10:54.978299
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pharmacological interventions for non-ulcer dyspepsia,Cochrane Database of Systematic Reviews,2006,10.1002/14651858.cd001960.pub3,https://experts.mcmaster.ca/display/publication695159,2025-07-27T15:10:54.978300
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding,Clinical Respiratory Journal,2006,10.1002/14651858.cd005415.pub2,https://experts.mcmaster.ca/display/publication695072,2025-07-27T15:10:54.978301
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Invited Commentary: Clues to the Etiology of Inflammatory Bowel Disease—A Return to John Snow?,American Journal of Epidemiology,2006,10.1093/aje/kwj261,https://experts.mcmaster.ca/display/publication695437,2025-07-27T15:10:54.978302
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Response to Dr. Zappa and Colleagues,American Journal of Gastroenterology,2006,10.1111/j.1572-0241.2006.00742_2.x,https://experts.mcmaster.ca/display/publication695435,2025-07-27T15:10:54.978303
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Distinguishing Organic and Functional Dyspepsia by History,Journal of the American Medical Association (JAMA),2006,10.1001/jama.296.11.1352-b,https://experts.mcmaster.ca/display/publication695421,2025-07-27T15:10:54.978304
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,In reply [8],Journal of the American Medical Association (JAMA),2006,10.1001/jama.296.11.1352-b,https://experts.mcmaster.ca/display/publication1747282,2025-07-27T15:10:54.978305
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori and gastro-oesophageal reflux disease – Authors' reply,The Lancet,2006,10.1016/s0140-6736(06)69406-3,https://experts.mcmaster.ca/display/publication695459,2025-07-27T15:10:54.978306
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Limited Value of Alarm Features in the Diagnosis of Upper Gastrointestinal Malignancy: Systematic Review and Meta-analysis,Gastroenterology,2006,10.1053/j.gastro.2006.04.029,https://experts.mcmaster.ca/display/publication695169,2025-07-27T15:10:54.978307
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus,American Journal of Gastroenterology,2006,10.1111/j.1572-0241.2006.00630.x,https://experts.mcmaster.ca/display/publication1466934,2025-07-27T15:10:54.978308
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.,Medscape women's health [electronic resource],2006,,https://experts.mcmaster.ca/display/publication1040560,2025-07-27T15:10:54.978309
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.,MedGenMed Medscape General Medicine,2006,,https://experts.mcmaster.ca/display/publication1040561,2025-07-27T15:10:54.978310
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastro-oesophageal reflux disease,The Lancet,2006,10.1016/s0140-6736(06)68932-0,https://experts.mcmaster.ca/display/publication695171,2025-07-27T15:10:54.978311
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Current Sedation and Monitoring Practice for Colonoscopy: An International Observational Study (EPAGE),Endoscopy,2006,10.1055/s-2006-925368,https://experts.mcmaster.ca/display/publication1747295,2025-07-27T15:10:54.978312
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication of Helicobacter pylori for non-ulcer dyspepsia,Clinical Respiratory Journal,2006,10.1002/14651858.cd002096.pub4,https://experts.mcmaster.ca/display/publication446519,2025-07-27T15:10:54.978313
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients,Cochrane Database of Systematic Reviews,2006,10.1002/14651858.cd003840.pub4,https://experts.mcmaster.ca/display/publication695297,2025-07-27T15:10:54.978314
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Can the Clinical History Distinguish Between Organic and Functional Dyspepsia?,Journal of the American Medical Association (JAMA),2006,10.1001/jama.295.13.1566,https://experts.mcmaster.ca/display/publication695128,2025-07-27T15:10:54.978315
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Colorectal Cancer Screening with Fecal Occult Blood Testing (FOBT): An International Perspective,American Journal of Gastroenterology,2006,10.1111/j.1572-0241.2006.00484.x,https://experts.mcmaster.ca/display/publication694968,2025-07-27T15:10:54.978316
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data,American Journal of Gastroenterology,2006,10.1111/j.1572-0241.2006.00537.x,https://experts.mcmaster.ca/display/publication695086,2025-07-27T15:10:54.978317
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Consensus on Medically Acceptable Wait Times for Digestive Health Care,Canadian Journal of Gastroenterology and Hepatology,2006,10.1155/2006/343686,https://experts.mcmaster.ca/display/publication1747296,2025-07-27T15:10:54.978318
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias,The Lancet Oncology,2006,10.1016/s1470-2045(05)70516-7,https://experts.mcmaster.ca/display/publication695379,2025-07-27T15:10:54.978320
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A Community Screening Program for Helicobacter pylori Saves Money: 10-Year Follow-up of a Randomized Controlled Trial,Gastroenterology,2005,10.1053/j.gastro.2005.09.016,https://experts.mcmaster.ca/display/publication695102,2025-07-27T15:10:54.978321
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastro-oesophageal reflux disease.,Clinical Evidence,2005,,https://experts.mcmaster.ca/display/publication1040562,2025-07-27T15:10:54.978322
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia,Gastroenterology,2005,10.1053/j.gastro.2005.09.020,https://experts.mcmaster.ca/display/publication695211,2025-07-27T15:10:54.978323
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial management strategies for dyspepsia,Clinical Respiratory Journal,2005,10.1002/14651858.cd001961.pub2,https://experts.mcmaster.ca/display/publication695313,2025-07-27T15:10:54.978324
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"PPIs effective for diagnosis, treatment of noncardiac chest pain.",Journal of Family Practice,2005,,https://experts.mcmaster.ca/display/publication695553,2025-07-27T15:10:54.978325
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's Esophagus",American Journal of Epidemiology,2005,10.1093/aje/kwi218,https://experts.mcmaster.ca/display/publication695272,2025-07-27T15:10:54.978326
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastroenterologists Overestimate the Appropriateness of Colonoscopies They Perform: An International Observational Study,Endoscopy,2005,10.1055/s-2005-870193,https://experts.mcmaster.ca/display/publication1747290,2025-07-27T15:10:54.978327
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique,American Journal of Gastroenterology,2005,10.1111/j.1572-0241.2005.41688.x,https://experts.mcmaster.ca/display/publication695098,2025-07-27T15:10:54.978328
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Erratum: Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents - An evidence-based evaluation (Canadian Journal of Gastroenterology (2005) vol. 19 (7) (399-408)),Canadian Journal of Gastroenterology,2005,,https://experts.mcmaster.ca/display/publication1747291,2025-07-27T15:10:54.978329
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review article: gastro‐oesophageal reflux disease – the extent of the problem,Alimentary Pharmacology and Therapeutics,2005,10.1111/j.1365-2036.2005.02605.x,https://experts.mcmaster.ca/display/publication695055,2025-07-27T15:10:54.978330
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis,American Journal of Gastroenterology,2005,10.1111/j.1572-0241.2005.41657.x,https://experts.mcmaster.ca/display/publication695116,2025-07-27T15:10:54.978331
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastro‐oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South‐East Asian patients with dyspepsia,Alimentary Pharmacology and Therapeutics,2005,10.1111/j.1365-2036.2005.02455.x,https://experts.mcmaster.ca/display/publication695373,2025-07-27T15:10:54.978332
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,Clinical Evidence,2005,,https://experts.mcmaster.ca/display/publication1040563,2025-07-27T15:10:54.978333
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori “Test and Treat” or Endoscopy for Managing Dyspepsia: An Individual Patient Data Meta-analysis,Gastroenterology,2005,10.1053/j.gastro.2005.03.004,https://experts.mcmaster.ca/display/publication695311,2025-07-27T15:10:54.978334
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales,Alimentary Pharmacology and Therapeutics,2005,10.1111/j.1365-2036.2005.02445.x,https://experts.mcmaster.ca/display/publication695371,2025-07-27T15:10:54.978335
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,PROTON PUMP INHIBITORS IN NONULCER DYSPEPSIA: STILL WORKING AFTER ALL THESE YEARS,Evidence-Based Gastroenterology,2005,10.1097/01.ebg.0000163172.48492.91,https://experts.mcmaster.ca/display/publication1747299,2025-07-27T15:10:54.978336
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The association between Helicobacter pylori infection and adult height,European Journal of Epidemiology (EJE),2005,10.1007/s10654-004-6634-0,https://experts.mcmaster.ca/display/publication695089,2025-07-27T15:10:54.978337
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease,Clinical Respiratory Journal,2005,10.1002/14651858.cd003245.pub2,https://experts.mcmaster.ca/display/publication695063,2025-07-27T15:10:54.978337
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychological interventions for non-ulcer dyspepsia,Clinical Respiratory Journal,2005,10.1002/14651858.cd002301.pub4,https://experts.mcmaster.ca/display/publication695289,2025-07-27T15:10:54.978338
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?,American Journal of Gastroenterology,2005,10.1111/j.1572-0241.2005.41779.x,https://experts.mcmaster.ca/display/publication695201,2025-07-27T15:10:54.978339
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Nonulcer dyspepsia and proton pump inhibitors,Gastroenterology,2005,10.1053/j.gastro.2005.01.024,https://experts.mcmaster.ca/display/publication1747285,2025-07-27T15:10:54.978340
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply,Gastroenterology,2005,10.1053/j.gastro.2005.01.025,https://experts.mcmaster.ca/display/publication695521,2025-07-27T15:10:54.978342
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori test-and-eradicate strategy versus early endoscopy in patients with dyspepsia,Nature Reviews Gastroenterology and Hepatology,2005,10.1038/ncpgasthep0091,https://experts.mcmaster.ca/display/publication694970,2025-07-27T15:10:54.978343
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Symptom-Based Outcome Measures for Dyspepsia and GERD Trials: A Systematic Review,American Journal of Gastroenterology,2005,10.1111/j.1572-0241.2005.40122.x,https://experts.mcmaster.ca/display/publication695188,2025-07-27T15:10:54.978344
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication of Helicobacter pylori for non-ulcer dyspepsia,Clinical Respiratory Journal,2005,10.1002/14651858.cd002096.pub2,https://experts.mcmaster.ca/display/publication446525,2025-07-27T15:10:54.978345
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Canadian Helicobacter Study Group Consensus Conference: Update on the Approach to Helicobacter Pylori Infection in Children and Adolescents – an Evidence-Based Evaluation,Canadian Journal of Gastroenterology and Hepatology,2005,10.1155/2005/390932,https://experts.mcmaster.ca/display/publication237413,2025-07-27T15:10:54.978346
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Measuring Gastroesophageal Reflux Symptoms: Musings from Marrakech,American Journal of Gastroenterology,2005,10.1111/j.1572-0241.2005.41603.x,https://experts.mcmaster.ca/display/publication695170,2025-07-27T15:10:54.978347
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Measuring gastroesophageal reflux symptoms: musings from Marrakech.,American Journal of Gastroenterology,2005,10.1111/j.1572-0241.2005.41603.x,https://experts.mcmaster.ca/display/publication1040565,2025-07-27T15:10:54.978348
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Should We Test for Helicobacter Pylori before Treating Gastroesophageal Reflux Disease?,Canadian Journal of Gastroenterology and Hepatology,2005,10.1155/2005/261835,https://experts.mcmaster.ca/display/publication695519,2025-07-27T15:10:54.978349
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,CON: Patients with GERD Should Be Screened Once at Least for Barrett's Esophagus-Medicine or Magic?,American Journal of Gastroenterology,2004,10.1111/j.1572-0241.2004.41295_2.x,https://experts.mcmaster.ca/display/publication695111,2025-07-27T15:10:54.978350
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,Clinical Evidence,2004,,https://experts.mcmaster.ca/display/publication1040564,2025-07-27T15:10:54.978351
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Meta-analysis: Can We Mix Apples and Oranges?,American Journal of Gastroenterology,2004,10.1111/j.1572-0241.2004.40948.x,https://experts.mcmaster.ca/display/publication695073,2025-07-27T15:10:54.978352
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis,Gastroenterology,2004,10.1053/j.gastro.2004.08.026,https://experts.mcmaster.ca/display/publication695353,2025-07-27T15:10:54.978353
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients,Cochrane Database of Systematic Reviews,2004,10.1002/14651858.cd003840.pub2,https://experts.mcmaster.ca/display/publication1040568,2025-07-27T15:10:54.978354
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pharmacological interventions for non-ulcer dyspepsia,Clinical Respiratory Journal,2004,10.1002/14651858.cd001960.pub2,https://experts.mcmaster.ca/display/publication1040569,2025-07-27T15:10:54.978355
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Cost-effectiveness and long-term impact of Helicobacter pylori ???test and treat??? service in reducing open access endoscopy referrals,European Journal of Gastroenterology and Hepatology,2004,10.1097/00042737-200410000-00005,https://experts.mcmaster.ca/display/publication695099,2025-07-27T15:10:54.978356
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A Systematic Review of Psychological Therapies for Nonulcer Dyspepsia,American Journal of Gastroenterology,2004,10.1111/j.1572-0241.2004.30086.x,https://experts.mcmaster.ca/display/publication695108,2025-07-27T15:10:54.978357
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis,American Journal of Gastroenterology,2004,10.1111/j.1572-0241.2004.40014.x,https://experts.mcmaster.ca/display/publication695347,2025-07-27T15:10:54.978358
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pyloriPublic Health Implications,Helicobacter,2004,10.1111/j.1083-4389.2004.00250.x,https://experts.mcmaster.ca/display/publication695074,2025-07-27T15:10:54.978359
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradicating H pylori,The BMJ,2004,10.1136/bmj.328.7453.1388,https://experts.mcmaster.ca/display/publication695162,2025-07-27T15:10:54.978360
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus,Journal of the National Cancer Institute,2004,10.1093/jnci/djh171,https://experts.mcmaster.ca/display/publication695177,2025-07-27T15:10:54.978361
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A glossary of economic terms,European Journal of Gastroenterology and Hepatology,2004,10.1097/00042737-200406000-00008,https://experts.mcmaster.ca/display/publication503468,2025-07-27T15:10:54.978362
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A glossary of economic terms,European Journal of Gastroenterology and Hepatology,2004,10.1097/00042737-200406000-00008,https://experts.mcmaster.ca/display/publication695284,2025-07-27T15:10:54.978363
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Cost-utility and cost-benefit analyses,European Journal of Gastroenterology and Hepatology,2004,10.1097/00042737-200406000-00004,https://experts.mcmaster.ca/display/publication695203,2025-07-27T15:10:54.978364
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastro-oesophageal reflux disease.,Clinical Evidence,2004,,https://experts.mcmaster.ca/display/publication1040566,2025-07-27T15:10:54.978365
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials,Gut,2004,10.1136/gut.2003.034371,https://experts.mcmaster.ca/display/publication695205,2025-07-27T15:10:54.978366
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Bringing science to the art of diagnosis,Gut,2004,10.1136/gut.2003.032219,https://experts.mcmaster.ca/display/publication694980,2025-07-27T15:10:54.978367
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,New approaches to enhance the accuracy of the diagnosis of reflux disease,Gut,2004,10.1136/gut.2003.034363,https://experts.mcmaster.ca/display/publication695126,2025-07-27T15:10:54.978368
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs",Gut,2004,10.1136/gut.2003.034272,https://experts.mcmaster.ca/display/publication695317,2025-07-27T15:10:54.978369
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Methods and Economic Considerations: Group 1 Report,Endoscopy,2004,10.1055/s-2004-814304,https://experts.mcmaster.ca/display/publication695057,2025-07-27T15:10:54.978370
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradikationstherapie bei Helicobacter-pylori-positiven Patienten mit Ulkuskrankheit,Praxis,2004,10.1024/0369-8394.93.14.566,https://experts.mcmaster.ca/display/publication1747289,2025-07-27T15:10:54.978371
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The methodological quality of trials affects estimates of treatment efficacy in functional (non‐ulcer) dyspepsia,Alimentary Pharmacology and Therapeutics,2004,10.1111/j.1365-2036.2004.01878.x,https://experts.mcmaster.ca/display/publication694988,2025-07-27T15:10:54.978372
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Uninvestigated dyspepsia and non‐ulcer dyspepsia—the use of endoscopy and the roles ofHelicobacter pylorieradication and antisecretory therapy,Alimentary Pharmacology and Therapeutics,2004,10.1111/j.0953-0673.2004.01829.x,https://experts.mcmaster.ca/display/publication695066,2025-07-27T15:10:54.978373
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychological interventions for non-ulcer dyspepsia,Cochrane Database of Systematic Reviews,2004,10.1002/14651858.cd002301.pub3,https://experts.mcmaster.ca/display/publication1040570,2025-07-27T15:10:54.978374
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychological interventions for non-ulcer dyspepsia,Cochrane Database of Systematic Reviews,2004,10.1002/14651858.cd002301.pub2,https://experts.mcmaster.ca/display/publication1040574,2025-07-27T15:10:54.978375
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,An Update of The Cochrane Systematic Review of Helicobacter Pylori Eradication Therapy in Nonulcer Dyspepsia: Resolving The Discrepancy Between Systematic Reviews,American Journal of Gastroenterology,2003,10.1111/j.1572-0241.2003.08724.x,https://experts.mcmaster.ca/display/publication695679,2025-07-27T15:10:54.978376
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.,American Journal of Gastroenterology,2003,10.1111/j.1572-0241.2003.08724.x,https://experts.mcmaster.ca/display/publication1040577,2025-07-27T15:10:54.978377
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,Clinical Evidence,2003,,https://experts.mcmaster.ca/display/publication1040567,2025-07-27T15:10:54.978378
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,JournalScan,Gut,2003,10.1136/gut.52.11.1653,https://experts.mcmaster.ca/display/publication1466937,2025-07-27T15:10:54.978379
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Dyspepsia results may not apply in primary care,The BMJ,2003,10.1136/bmj.327.7418.811-a,https://experts.mcmaster.ca/display/publication695228,2025-07-27T15:10:54.978380
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,JournalScan,Gut,2003,10.1136/gut.52.9.1382,https://experts.mcmaster.ca/display/publication1466938,2025-07-27T15:10:54.978381
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,JournalScan,Gut,2003,10.1136/gut.52.8.1219,https://experts.mcmaster.ca/display/publication1466939,2025-07-27T15:10:54.978382
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Gastro-oesophageal reflux disease.,Clinical Evidence,2003,,https://experts.mcmaster.ca/display/publication1040581,2025-07-27T15:10:54.978383
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,American Family Physician,2003,,https://experts.mcmaster.ca/display/publication1040586,2025-07-27T15:10:54.978384
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Mycophenolate mofetil in refractory inflammatory bowel disease,Alimentary Pharmacology and Therapeutics,2003,10.1046/j.1365-2036.2003.01581.x,https://experts.mcmaster.ca/display/publication695172,2025-07-27T15:10:54.978385
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Systematic review: antacids, H2‐receptor antagonists, prokinetics, bismuth and sucralfate therapy for non‐ulcer dyspepsia",Alimentary Pharmacology and Therapeutics,2003,10.1046/j.1365-2036.2003.01575.x,https://experts.mcmaster.ca/display/publication695303,2025-07-27T15:10:54.978386
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication of Helicobacter pylori for non-ulcer dyspepsia.,Cochrane Database of Systematic Reviews,2003,10.1002/14651858.CD002096,https://experts.mcmaster.ca/display/publication929645,2025-07-27T15:10:54.978387
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients,Clinical Respiratory Journal,2003,10.1002/14651858.cd003840,https://experts.mcmaster.ca/display/publication1040579,2025-07-27T15:10:54.978388
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection in subjects with acute ischaemic stroke,Digestive and Liver Disease,2003,10.1016/s1590-8658(02)00005-1,https://experts.mcmaster.ca/display/publication695112,2025-07-27T15:10:54.978389
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,How Can the Current Strategies forHelicobacter pyloriEradication Therapy be Improved?,Canadian Journal of Gastroenterology and Hepatology,2003,10.1155/2003/714124,https://experts.mcmaster.ca/display/publication1040583,2025-07-27T15:10:54.978390
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial management strategies for dyspepsia,Cochrane Database of Systematic Reviews,2003,10.1002/14651858.cd001961,https://experts.mcmaster.ca/display/publication1040585,2025-07-27T15:10:54.978391
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pharmacological interventions for non-ulcer dyspepsia,Clinical Respiratory Journal,2003,10.1002/14651858.cd001960,https://experts.mcmaster.ca/display/publication1040593,2025-07-27T15:10:54.978392
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Recent developments in gastroenterology,The BMJ,2002,10.1136/bmj.325.7377.1399,https://experts.mcmaster.ca/display/publication695196,2025-07-27T15:10:54.978393
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,Clinical Evidence,2002,,https://experts.mcmaster.ca/display/publication1040591,2025-07-27T15:10:54.978394
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pyloriand nonmalignant disease,Helicobacter,2002,10.1046/j.1523-5378.7.s1.5.x,https://experts.mcmaster.ca/display/publication695051,2025-07-27T15:10:54.978395
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Bile reflux gastritis and intestinal metaplasia at the cardia,Gut,2002,10.1136/gut.51.3.351,https://experts.mcmaster.ca/display/publication695061,2025-07-27T15:10:54.978396
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helping patients to help themselves: the future for management of ulcerative colitis?,Gut,2002,10.1136/gut.51.3.309,https://experts.mcmaster.ca/display/publication694959,2025-07-27T15:10:54.978397
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection.,Clinical Evidence,2002,,https://experts.mcmaster.ca/display/publication1040595,2025-07-27T15:10:54.978398
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection,International Journal of Epidemiology,2002,10.1093/ije/31.3.624,https://experts.mcmaster.ca/display/publication695093,2025-07-27T15:10:54.978399
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pyloriEradication Therapy for Nonulcer Dyspepsia,ACP journal club,2002,10.7326/0003-4819-136-7-200204020-00016,https://experts.mcmaster.ca/display/publication695824,2025-07-27T15:10:54.978400
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysis,European Journal of Gastroenterology and Hepatology,2002,10.1097/00042737-200204000-00017,https://experts.mcmaster.ca/display/publication695091,2025-07-27T15:10:54.978400
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease,European Journal of Gastroenterology and Hepatology,2002,10.1097/00042737-200203000-00008,https://experts.mcmaster.ca/display/publication694992,2025-07-27T15:10:54.978401
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The cost‐effectiveness of populationHelicobacter pyloriscreening and treatment: a Markov model using economic data from a randomized controlled trial,Alimentary Pharmacology and Therapeutics,2002,10.1046/j.1365-2036.2002.01204.x,https://experts.mcmaster.ca/display/publication695163,2025-07-27T15:10:54.978402
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west,Gastroenterology,2002,10.1053/gast.2002.31599,https://experts.mcmaster.ca/display/publication695181,2025-07-27T15:10:54.978403
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease,Gastroenterology,2001,10.1053/gast.2001.29332,https://experts.mcmaster.ca/display/publication694965,2025-07-27T15:10:54.978404
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Counting the cost of proton pump inhibitors,Gut,2001,10.1136/gut.49.4.462,https://experts.mcmaster.ca/display/publication694976,2025-07-27T15:10:54.978405
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Acridine orange stain in the histological identification of Helicobacter pylori,Journal of Clinical Pathology - Clinical Molecular Pathology,2001,10.1136/jcp.54.9.734,https://experts.mcmaster.ca/display/publication695906,2025-07-27T15:10:54.978406
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?,Gut,2001,10.1136/gut.49.3.359,https://experts.mcmaster.ca/display/publication695047,2025-07-27T15:10:54.978407
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Dyspepsia: The Clinical Consequences.,Gut,2001,10.1136/gut.49.2.314,https://experts.mcmaster.ca/display/publication1466940,2025-07-27T15:10:54.978408
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori: a clinical update,Journal of Applied Microbiology,2001,10.1046/j.1365-2672.2001.01361.x,https://experts.mcmaster.ca/display/publication695059,2025-07-27T15:10:54.978409
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients (vol 33, pg 132, 2001)",Digestive and Liver Disease,2001,,https://experts.mcmaster.ca/display/publication695896,2025-07-27T15:10:54.978410
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial management strategies for dyspepsia,Praxis,2001,,https://experts.mcmaster.ca/display/publication1747298,2025-07-27T15:10:54.978411
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Randomised study ofefficacy of Omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients,Digestive and Liver Disease,2001,10.1016/s1590-8658(01)80067-0,https://experts.mcmaster.ca/display/publication694963,2025-07-27T15:10:54.978412
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Review: prokinetics and histamine-2 receptor antagonists improve symptom scores in non-ulcer dyspepsia,BMJ Evidence-Based Medicine,2001,10.1136/ebm.6.2.47,https://experts.mcmaster.ca/display/publication1747294,2025-07-27T15:10:54.978413
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial management strategies for dyspepsia.,Cochrane Database of Systematic Reviews,2001,10.1002/14651858.CD001961,https://experts.mcmaster.ca/display/publication1040611,2025-07-27T15:10:54.978414
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Psychological interventions for non-ulcer dyspepsia,Clinical Respiratory Journal,2001,10.1002/14651858.cd002301,https://experts.mcmaster.ca/display/publication1040609,2025-07-27T15:10:54.978415
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Changing Patterns ofHelicobacter pyloriGastritis in Long‐Standing Acid Suppression,Helicobacter,2000,10.1046/j.1523-5378.2000.00032.x,https://experts.mcmaster.ca/display/publication695065,2025-07-27T15:10:54.978416
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Histological identification ofHelicobacter pylori: comparison of staining methods,Journal of Clinical Pathology - Clinical Molecular Pathology,2000,10.1136/jcp.53.10.756,https://experts.mcmaster.ca/display/publication695044,2025-07-27T15:10:54.978417
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia,The BMJ,2000,10.1136/bmj.321.7262.659,https://experts.mcmaster.ca/display/publication695349,2025-07-27T15:10:54.978418
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"The effectiveness of omeprazole, clarithromycin and tinidazole in eradicatingHelicobacter pyloriin a community screen and treat programme",Alimentary Pharmacology and Therapeutics,2000,10.1046/j.1365-2036.2000.00767.x,https://experts.mcmaster.ca/display/publication696036,2025-07-27T15:10:54.978419
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"The proportion of upper gastrointestinal symptoms in the community associated with helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs",American Journal of Gastroenterology,2000,10.1111/j.1572-0241.2000.2126_1.x,https://experts.mcmaster.ca/display/publication696024,2025-07-27T15:10:54.978420
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial,The Lancet,2000,10.1016/s0140-6736(00)02236-4,https://experts.mcmaster.ca/display/publication695230,2025-07-27T15:10:54.978421
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradicating war is essential to eliminate poverty and improve health,The BMJ,2000,10.1136/bmj.320.7243.1208,https://experts.mcmaster.ca/display/publication694957,2025-07-27T15:10:54.978422
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Studies included in meta-analysis had heterogenous, not homogenous, results.",The BMJ,2000,10.1136/bmj.320.7243.1208,https://experts.mcmaster.ca/display/publication1747271,2025-07-27T15:10:54.978423
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? This meta-analysis is potentially misleading.,The BMJ,2000,10.1136/bmj.320.7243.1208,https://experts.mcmaster.ca/display/publication695677,2025-07-27T15:10:54.978424
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Finding the optimum treatment for Helicobacter pylori,Digestive and Liver Disease,2000,10.1016/s1590-8658(00)80396-5,https://experts.mcmaster.ca/display/publication695048,2025-07-27T15:10:54.978425
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Eradication of helicobacter pylori for non-ulcer dyspepsia.,Cochrane Database of Systematic Reviews,2000,10.1002/14651858.CD002096,https://experts.mcmaster.ca/display/publication929678,2025-07-27T15:10:54.978425
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Initial management strategies for dyspepsia.,Cochrane Database of Systematic Reviews,2000,10.1002/14651858.CD001961,https://experts.mcmaster.ca/display/publication1040624,2025-07-27T15:10:54.978426
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pharmacological interventions for non-ulcer dyspepsia.,Cochrane Database of Systematic Reviews,2000,10.1002/14651858.CD001960,https://experts.mcmaster.ca/display/publication1040625,2025-07-27T15:10:54.978427
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The management of dyspepsia: a systematic review.,Health Technology Assessment,2000,10.3310/hta4390,https://experts.mcmaster.ca/display/publication1040617,2025-07-27T15:10:54.978428
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Usefulness of The Likelihood Ratio in The Diagnosis of Dyspepsia and Gastroesophageal Reflux Disease,American Journal of Gastroenterology,1999,10.1111/j.1572-0241.1999.01502.x,https://experts.mcmaster.ca/display/publication695991,2025-07-27T15:10:54.978429
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia,European Journal of Gastroenterology and Hepatology,1999,10.1097/00042737-199911000-00010,https://experts.mcmaster.ca/display/publication695002,2025-07-27T15:10:54.978430
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,5‐DayH. pylorieradication,Alimentary Pharmacology and Therapeutics,1999,10.1046/j.1365-2036.1999.0612c.x,https://experts.mcmaster.ca/display/publication1747293,2025-07-27T15:10:54.978431
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Reply — 5‐DayH. pylorieradication,Alimentary Pharmacology and Therapeutics,1999,10.1046/j.1365-2036.1999.0612d.x,https://experts.mcmaster.ca/display/publication695955,2025-07-27T15:10:54.978432
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Do young dyspeptics require endoscopy any more?,European Journal of Gastroenterology and Hepatology,1999,10.1097/00042737-199908002-00012,https://experts.mcmaster.ca/display/publication695095,2025-07-27T15:10:54.978433
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Should we go further and screen and treat? Discussion III,European Journal of Gastroenterology and Hepatology,1999,,https://experts.mcmaster.ca/display/publication696026,2025-07-27T15:10:54.978434
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy,American Journal of Kidney Diseases,1999,10.1016/s0272-6386(99)70141-1,https://experts.mcmaster.ca/display/publication695291,2025-07-27T15:10:54.978436
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Correlation between epithelial cell proliferation and histological grading in gastric mucosa.,Journal of Clinical Pathology - Clinical Molecular Pathology,1999,10.1136/jcp.52.5.367,https://experts.mcmaster.ca/display/publication502563,2025-07-27T15:10:54.978437
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The optimal antibiotic combination in a 5‐dayHelicobacter pylorieradication regimen,Alimentary Pharmacology and Therapeutics,1999,10.1046/j.1365-2036.1999.00493.x,https://experts.mcmaster.ca/display/publication695746,2025-07-27T15:10:54.978437
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,POPULATION-BASED AND OPPORTUNISTIC SCREENING AND ERADICATION OFHELICOBACTER PYLORI,International Journal of Technology Assessment in Health Care,1999,10.1017/s0266462399015445,https://experts.mcmaster.ca/display/publication695174,2025-07-27T15:10:54.978438
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia,Alimentary Pharmacology and Therapeutics,1998,10.1046/j.1365-2036.1998.00404.x,https://experts.mcmaster.ca/display/publication695549,2025-07-27T15:10:54.978439
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori",Journal of Gastroenterology,1998,10.1007/s005350050064,https://experts.mcmaster.ca/display/publication695068,2025-07-27T15:10:54.978440
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,The Serum13C‐Bicarbonate Assay: A Replacement for Urea Breath Tests? Vector Potential of Houseflies (Musca domestica) forHelicobacter pylori. Reflux Esophagitis in Duodenal Ulcer Patients,Helicobacter,1998,10.1046/j.1523-5378.1998.08033.x,https://experts.mcmaster.ca/display/publication694982,2025-07-27T15:10:54.978441
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Genetic variability and characterization of non-structural region 5 of hepatitis C virus genome from Chinese patients,Journal of Gastroenterology,1998,10.1007/s005350050046,https://experts.mcmaster.ca/display/publication695816,2025-07-27T15:10:54.978442
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for,British Medical Bulletin,1998,10.1093/oxfordjournals.bmb.a011674,https://experts.mcmaster.ca/display/publication695878,2025-07-27T15:10:54.978443
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,What is the optimum strategy for managing dyspepsia?,Journal of Gastroenterology,1998,,https://experts.mcmaster.ca/display/publication695882,2025-07-27T15:10:54.978444
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?,Digestive and Liver Disease,1997,,https://experts.mcmaster.ca/display/publication695876,2025-07-27T15:10:54.978445
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography,Cardiovascular Research (CVR),1997,10.1016/s0008-6363(97)00090-4,https://experts.mcmaster.ca/display/publication694972,2025-07-27T15:10:54.978446
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection,The BMJ,1997,10.1136/bmj.314.7095.1688a,https://experts.mcmaster.ca/display/publication1747270,2025-07-27T15:10:54.978447
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection - Reply,The BMJ,1997,,https://experts.mcmaster.ca/display/publication695971,2025-07-27T15:10:54.978448
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. Conflicting results from the Helisal test.,The BMJ,1997,10.1136/bmj.314.7095.1688a,https://experts.mcmaster.ca/display/publication1747292,2025-07-27T15:10:54.978449
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin.",Journal of Clinical Pathology - Clinical Molecular Pathology,1997,10.1136/jcp.50.6.527,https://experts.mcmaster.ca/display/publication502584,2025-07-27T15:10:54.978450
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Do patients need to fast for a 13C-urea breath test?,European Journal of Gastroenterology and Hepatology,1997,10.1097/00042737-199703000-00010,https://experts.mcmaster.ca/display/publication695056,2025-07-27T15:10:54.978451
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Mouth‐Watering Prospects forHelicobacter pyloriDiagnosis?,Helicobacter,1997,10.1111/j.1523-5378.1997.tb00059.x,https://experts.mcmaster.ca/display/publication696052,2025-07-27T15:10:54.978452
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection,The BMJ,1997,10.1136/bmj.314.7074.119,https://experts.mcmaster.ca/display/publication695898,2025-07-27T15:10:54.978453
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicateHelicobacter pylori",Journal of Gastroenterology,1997,10.1007/bf01213292,https://experts.mcmaster.ca/display/publication695094,2025-07-27T15:10:54.978454
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Significance of Helicobacter Pylori Infection and Gastric Cancer: Implications for Screening,Gastrointestinal Endoscopy Clinics of North America,1997,10.1016/s1052-5157(18)30322-2,https://experts.mcmaster.ca/display/publication1040626,2025-07-27T15:10:54.978455
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"Comparison of One or Two Weeks of Lansoprazole, Amoxicillin, and Clarithromycin in the Treatment of Helicobacter pylori",Helicobacter,1996,10.1111/j.1523-5378.1996.tb00012.x,https://experts.mcmaster.ca/display/publication1040628,2025-07-27T15:10:54.978456
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,OVER THE FENCE,Helicobacter,1996,10.1111/j.1523-5378.1996.tb00023.x,https://experts.mcmaster.ca/display/publication1040627,2025-07-27T15:10:54.978457
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,"The Influence of Helicobacter pylori Status on Circulating Levels of the Coagulation Factors Fibrinogen, von Willebrand Factor, Factor VII, and Factor VIII",Helicobacter,1996,10.1111/j.1523-5378.1996.tb00011.x,https://experts.mcmaster.ca/display/publication1040629,2025-07-27T15:10:54.978458
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Endoscopy and Gastric Ulcers,Endoscopy,1995,10.1055/s-2007-1005789,https://experts.mcmaster.ca/display/publication695665,2025-07-27T15:10:54.978459
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Helicobacter pylori: the research explosion,Current Opinion in Infectious Diseases,1995,10.1097/00001432-199510000-00010,https://experts.mcmaster.ca/display/publication696063,2025-07-27T15:10:54.978460
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Mesangiocapillary glomerulonephritis associated with ulcerative colitis: case reports of two patients.,Nephrology Dialysis Transplantation,1995,10.1093/oxfordjournals.ndt.a090891,https://experts.mcmaster.ca/display/publication695088,2025-07-27T15:10:54.978461
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.,European Journal of Gastroenterology and Hepatology,1995,,https://experts.mcmaster.ca/display/publication695085,2025-07-27T15:10:54.978462
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.,Thorax,1995,10.1136/thx.50.8.834,https://experts.mcmaster.ca/display/publication695107,2025-07-27T15:10:54.978463
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,SALIVARY ANTIBODIES TO HELICOBACTER-PYLORI - SCREENING DYSPEPTIC PATIENTS BEFORE ENDOSCOPY,The Lancet,1994,,https://experts.mcmaster.ca/display/publication695872,2025-07-27T15:10:54.978464
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy,The Lancet,1994,10.1016/s0140-6736(94)91672-1,https://experts.mcmaster.ca/display/publication694978,2025-07-27T15:10:54.978465
Paul Moayyedi,moayyep@mcmaster.ca,journal_articles,Pseudomonas and Endoscopy,Endoscopy,1994,10.1055/s-2007-1009033,https://experts.mcmaster.ca/display/publication695092,2025-07-27T15:10:54.978466
Paul Moayyedi,moayyep@mcmaster.ca,chapters,"Epidemiology, Microbiome, and Risk Factors Involved in Carcinogenesis of Colorectal Cancer",,2024,10.1002/9781119756422.ch9,https://experts.mcmaster.ca/display/publication3452399,2025-07-27T15:10:54.978467
Paul Moayyedi,moayyep@mcmaster.ca,chapters,WHAT IS THE ROLE OF TRICYCLIC ANTIDEPRESSANTS IN THE TREATMENT OF IBS?,,2024,10.1201/9781003523574-40,https://experts.mcmaster.ca/display/publication3467937,2025-07-27T15:10:54.978468
Paul Moayyedi,moayyep@mcmaster.ca,chapters,Diagnostic Studies,,2014,10.1002/9781118727072.ch11,https://experts.mcmaster.ca/display/publication1747272,2025-07-27T15:10:54.978469
Paul Moayyedi,moayyep@mcmaster.ca,chapters,How to Read a Systematic Review and Meta‐Analysis,,2014,10.1002/9781118727072.ch5,https://experts.mcmaster.ca/display/publication1747274,2025-07-27T15:10:54.978470
Paul Moayyedi,moayyep@mcmaster.ca,chapters,Randomized Controlled Trials,,2014,10.1002/9781118727072.ch12,https://experts.mcmaster.ca/display/publication1747273,2025-07-27T15:10:54.978471
Paul Moayyedi,moayyep@mcmaster.ca,chapters,Dyspepsia: Ulcer and Non‐Ulcer/Bloating and Early Satiety/Belching and Rumination,,2012,10.1002/9781118321386.ch4,https://experts.mcmaster.ca/display/publication1747277,2025-07-27T15:10:54.978472
Paul Moayyedi,moayyep@mcmaster.ca,chapters,Irritable Bowel Syndrome,,2010,10.1002/9781444314403.ch21,https://experts.mcmaster.ca/display/publication1747280,2025-07-27T15:10:54.978473
Paul Moayyedi,moayyep@mcmaster.ca,chapters,Epidemiology and Prevention of Colorectal Cancer,,2008,10.1002/9781444300147.ch11,https://experts.mcmaster.ca/display/publication1747278,2025-07-27T15:10:54.978474
Paul Moayyedi,moayyep@mcmaster.ca,chapters,Meta‐Analyses,,2007,10.1002/9780470692189.ch10,https://experts.mcmaster.ca/display/publication1747279,2025-07-27T15:10:54.978475
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicenter Prospective Cohort Study.,Gastroenterology,2025,10.1053/j.gastro.2024.08.021,https://experts.mcmaster.ca/display/publication3412860,2025-07-27T15:10:54.978476
Paul Moayyedi,moayyep@mcmaster.ca,conferences,DISCLOSURE OF DIET TRIGGERS DOES NOT ALTER DIETARY CHOICES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND SELFREPORTED GLUTEN SENSITIVITY,Gastroenterology,2024,,https://experts.mcmaster.ca/display/publication3513027,2025-07-27T15:10:54.978477
Paul Moayyedi,moayyep@mcmaster.ca,conferences,IDENTIFYING BLOOD BIOMARKERS THAT PREDICT INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL AND MENDELIAN RANDOMIZATION STUDY,Gastroenterology,2024,,https://experts.mcmaster.ca/display/publication3566574,2025-07-27T15:10:54.978478
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Interactive training with a novel simulation model for upper gastrointestinal endoscopic hemostasis improves trainee technique and confidence,Endoscopy International Open,2024,10.1055/a-2248-5110,https://experts.mcmaster.ca/display/publication2175539,2025-07-27T15:10:54.978479
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis,Gastroenterology,2023,10.1053/j.gastro.2023.07.018,https://experts.mcmaster.ca/display/publication695852,2025-07-27T15:10:54.978480
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,Critical Care Medicine,2022,10.1097/ccm.0000000000005580,https://experts.mcmaster.ca/display/publication2175546,2025-07-27T15:10:54.978481
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-Analysis,American Journal of Gastroenterology,2021,,https://experts.mcmaster.ca/display/publication2154085,2025-07-27T15:10:54.978482
Paul Moayyedi,moayyep@mcmaster.ca,conferences,OP05 Association of ultra-processed food intake with risk of Inflammatory Bowel Disease from the prospective urban rural epidemiology (PURE) study: A prospective cohort study,Journal of Crohn's and Colitis,2021,10.1093/ecco-jcc/jjab075.004,https://experts.mcmaster.ca/display/publication2141830,2025-07-27T15:10:54.978483
Paul Moayyedi,moayyep@mcmaster.ca,conferences,ASSOCIATION OF PROCESSED FOOD INTAKE WITH RISK OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY,Gastroenterology,2021,,https://experts.mcmaster.ca/display/publication2175541,2025-07-27T15:10:54.978484
Paul Moayyedi,moayyep@mcmaster.ca,conferences,FECAL IMMUNOCHEMICAL TEST (FIT) VERSUS CY(CY) IN DETECTING ADVANCED COLON NEOPLASIA: A DIAGNOSTIC TEST ACCURACY META-ANALYSIS INCLUDING A HEAD-TO-HEAD COMPARISON OF FIT AND CY,Gastroenterology,2021,,https://experts.mcmaster.ca/display/publication2088747,2025-07-27T15:10:54.978485
Paul Moayyedi,moayyep@mcmaster.ca,conferences,INTESTINAL PERMEABILITY IN HEALTHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCIATED WITH ENVIRONMENTAL AND DEMOGRAPHIC FACTORS RATHER THAN CROHN'S DISEASE POLYGENIC RISK SCORE,Gastroenterology,2021,,https://experts.mcmaster.ca/display/publication2175540,2025-07-27T15:10:54.978486
Paul Moayyedi,moayyep@mcmaster.ca,conferences,RESULTS OF THE FIRST PILOT RANDOMIZED CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR PEDIATRIC ULCERATIVE COLITIS,Gastroenterology,2021,,https://experts.mcmaster.ca/display/publication2131432,2025-07-27T15:10:54.978487
Paul Moayyedi,moayyep@mcmaster.ca,conferences,IMPROVING PATIENT PARTICIPATION IN LONGITUDINAL RESEARCH: AN INNOVATIVE PATIENT-LED PATIENT-ORIENTED QUALITATIVE RESEARCH PROJECT TO UNDERSTAND THE MOTIVATIONS AND BARRIERS TO GETTING AND STAYING INVOLVED IN THE IMAGINE SPOR STUDY,Gastroenterology,2021,,https://experts.mcmaster.ca/display/publication2175543,2025-07-27T15:10:54.978488
Paul Moayyedi,moayyep@mcmaster.ca,conferences,IMPROVING PATIENT PARTICIPATION IN LONGITUDINAL RESEARCH: AN INNOVATIVE PATIENT-LED PATIENT-ORIENTED QUALITATIVE RESEARCH PROJECT TO UNDERSTAND THE MOTIVATIONS AND BARRIERS TO GETTING AND STAYING INVOLVED IN THE IMAGINE SPOR STUDY,Inflammatory Bowel Diseases,2021,10.1093/ibd/izaa347.119,https://experts.mcmaster.ca/display/publication2175542,2025-07-27T15:10:54.978489
Paul Moayyedi,moayyep@mcmaster.ca,conferences,O61 Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis,Gut,2021,10.1136/gutjnl-2020-bsgcampus.61,https://experts.mcmaster.ca/display/publication2136362,2025-07-27T15:10:54.978489
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis,Gut,2020,10.1136/gutjnl-2020-321191,https://experts.mcmaster.ca/display/publication695834,2025-07-27T15:10:54.978490
Paul Moayyedi,moayyep@mcmaster.ca,conferences,PREVALENCE AND RISK FACTORS FOR LYMPH NODE METASTASIS AFTER NONCURATIVE ENDOSCOPIC RESECTION FOR EARLY ASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS,Gastrointestinal Endoscopy,2020,,https://experts.mcmaster.ca/display/publication1962326,2025-07-27T15:10:54.978491
Paul Moayyedi,moayyep@mcmaster.ca,conferences,REDUCING ANXIETY IN PATIENTS UNDERGOING FIRST-TIME COLONOSCOPY: A PILOT AND FEASIBILITY STUDY FOR RANDOMIZED CONTROLLED TRIAL,Gastrointestinal Endoscopy,2020,,https://experts.mcmaster.ca/display/publication1962189,2025-07-27T15:10:54.978492
Paul Moayyedi,moayyep@mcmaster.ca,conferences,CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2175548,2025-07-27T15:10:54.978493
Paul Moayyedi,moayyep@mcmaster.ca,conferences,FEASIBILITY OF THE FIRST PAEDIATRIC RANDOMIZED CONTROLLED PILOT TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2131433,2025-07-27T15:10:54.978494
Paul Moayyedi,moayyep@mcmaster.ca,conferences,RESULTS OF THE FIRST PAEDIATRIC RANDOMIZED-CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2131434,2025-07-27T15:10:54.978495
Paul Moayyedi,moayyep@mcmaster.ca,conferences,THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2175549,2025-07-27T15:10:54.978496
Paul Moayyedi,moayyep@mcmaster.ca,conferences,THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2175545,2025-07-27T15:10:54.978497
Paul Moayyedi,moayyep@mcmaster.ca,conferences,THE GEM PROJECT: IMPAIRED GUT BARRIER FUNCTION IS ASSOCIATED WITH FUTURE DEVELOPMENT OF CROHN'S DISEASE EVEN IN THE PRESENCE OR ABSCENCE OF PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S PATIENTS,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2175547,2025-07-27T15:10:54.978498
Paul Moayyedi,moayyep@mcmaster.ca,conferences,THE UTILITY OF GLUCOSE HYDROGEN BREATH TEST IN IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW,Gastroenterology,2020,,https://experts.mcmaster.ca/display/publication2088748,2025-07-27T15:10:54.978499
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Feasibility of the first paediatric randomised controlled pilot trial of faecal microbiota transplant for ulcerative colitis,Journal of Crohn's and Colitis,2020,,https://experts.mcmaster.ca/display/publication1703384,2025-07-27T15:10:54.978500
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Perceptions of faecal microbiota transplantation in patients with ulcerative colitis,Journal of Crohn's and Colitis,2020,,https://experts.mcmaster.ca/display/publication1702654,2025-07-27T15:10:54.978501
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Results of the first paediatric randomised controlled trial of faecal microbiota transplant for ulcerative colitis,Journal of Crohn's and Colitis,2020,,https://experts.mcmaster.ca/display/publication1703383,2025-07-27T15:10:54.978502
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Understanding Patients' Perceptions of Fecal Microbiota Transplant,American Journal of Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication1689281,2025-07-27T15:10:54.978503
Paul Moayyedi,moayyep@mcmaster.ca,conferences,2885 Reducing Anxiety in Patients Undergoing First-Time Colonoscopy: A Pilot and Feasibility Study for a Randomized Controlled Trial,American Journal of Gastroenterology,2019,10.14309/01.ajg.0000601072.36785.82,https://experts.mcmaster.ca/display/publication1694712,2025-07-27T15:10:54.978504
Paul Moayyedi,moayyep@mcmaster.ca,conferences,PWE-076 Efficacy of Pharmacological Therapies in Patients with Irritable Bowel Syndrome with Diarrhoea: Network Meta-analysis,Gut,2019,10.1136/gutjnl-2019-bsgabstracts.396,https://experts.mcmaster.ca/display/publication1703655,2025-07-27T15:10:54.978505
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A RANDOMIZED TRIAL OF PROTON PUMP INHIBITORS VERSUS PLACEBO TO PREVENT UPPER GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING RIVAROXABAN OR ASPIRIN,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication1683518,2025-07-27T15:10:54.978506
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"ADVERSE EVENTS RELATED TO PROTON PUMP INHIBITOR THERAPY. RESULTS OF A RANDOMIZED TRIAL OF PANTOPRAZOLE VERSUS PLACEBO WITH 53,152 PATIENT YEARS OF FOLLOW-UP",Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication1683517,2025-07-27T15:10:54.978507
Paul Moayyedi,moayyep@mcmaster.ca,conferences,EFFECTS OF PROTON-PUMP INHIBITORS IN PATIENTS RECEIVING CLOPIDOGREL-BASED ANTITHROMBOTIC THERAPY FOR CARDIOVASCULAR PREVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication1683516,2025-07-27T15:10:54.978508
Paul Moayyedi,moayyep@mcmaster.ca,conferences,ELEVATED FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH FUTURE DIAGNOSIS OF CROHN'S DISEASE,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication2175563,2025-07-27T15:10:54.978508
Paul Moayyedi,moayyep@mcmaster.ca,conferences,INCREASED INTESTINAL PERMEABILITY IS A PREDICTOR OF CROHN'S DISEASE DEVELOPMENT IN A LARGE COHORT OF ASYMPTOMATIC FIRST DEGREE RELATIVES,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication2175565,2025-07-27T15:10:54.978509
Paul Moayyedi,moayyep@mcmaster.ca,conferences,PATIENT PERCEPTIONS OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATENT OF ULCERATIVE COLITIS,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication2175566,2025-07-27T15:10:54.978510
Paul Moayyedi,moayyep@mcmaster.ca,conferences,PROTON PUMP INHIBITOR TREATMENT INITIATED PRIOR TO ENDOSCOPY IC DIAGNOSIS IN UPPER GASTROINTESTINAL BLEEDING: AN UPDATED COCHRANE COLLABORATION SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication2088752,2025-07-27T15:10:54.978511
Paul Moayyedi,moayyep@mcmaster.ca,conferences,VALIDATION OF THE BRISTOL STOOL CHART AND THE BLISS STOOL CLASSIFICATION SYSTEM IN THE INTENSIVE CARE UNIT,Gastroenterology,2019,,https://experts.mcmaster.ca/display/publication2175564,2025-07-27T15:10:54.978512
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.,Journal of Clinical Oncology,2018,10.1200/jco.2018.36.18_suppl.lba4008,https://experts.mcmaster.ca/display/publication1615583,2025-07-27T15:10:54.978513
Paul Moayyedi,moayyep@mcmaster.ca,conferences,EXCLUSION DIETS AND IRRITABLE BOWEL SYMPTOMS: A SYSTEMATIC REVIEW AND META-ANALYSIS,Gastroenterology,2018,,https://experts.mcmaster.ca/display/publication2088753,2025-07-27T15:10:54.978514
Paul Moayyedi,moayyep@mcmaster.ca,conferences,ROLE OF PROKINETICS IN SYMPTOM IMPROVEMENT OF FUNCTIONAL DYSPEPSIA: COCHRANE COLLABORATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS,Gastroenterology,2018,,https://experts.mcmaster.ca/display/publication2088754,2025-07-27T15:10:54.978515
Paul Moayyedi,moayyep@mcmaster.ca,conferences,THE PREVALENCE OF CELIAC DISEASE IS INCREASED IN PATIENTS WITH BARRETT'S ESOPHAGUS AND IS ASSOCIATED WITH EARLY DEVELOPMENT OF DYSPLASIA,Gastroenterology,2018,,https://experts.mcmaster.ca/display/publication1612429,2025-07-27T15:10:54.978516
Paul Moayyedi,moayyep@mcmaster.ca,conferences,PWE-124 Daily aspirin 300mg: how much do patients take? drug accountability for the first 5 years of the aspect study,Gut,2017,10.1136/gutjnl-2017-314472.369,https://experts.mcmaster.ca/display/publication1510925,2025-07-27T15:10:54.978517
Paul Moayyedi,moayyep@mcmaster.ca,conferences,ANTIGLIADIN ANTIBODIES PREDICT THE SYMPTOMATIC RESPONSE TO GLUTEN-FREE DIET AND IMPROVEMENT IN GASTROINTESTINAL MOTILITY IN IBS PATIENTS,Gastroenterology,2017,,https://experts.mcmaster.ca/display/publication522508,2025-07-27T15:10:54.978518
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia,Gastroenterology,2017,10.1016/s0016-5085(17)33201-8,https://experts.mcmaster.ca/display/publication522479,2025-07-27T15:10:54.978519
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"No Detrimental Effect of Oats on Symptoms, Histological Parameters, Serological Tests, or Quality of Life in Celiac Disease: A Systematic Review and Meta-Analysis",Gastroenterology,2017,10.1016/s0016-5085(17)31795-x,https://experts.mcmaster.ca/display/publication522481,2025-07-27T15:10:54.978520
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"PTU-149 Barrett’s Oesophagus Patients Attending Hospital: Baseline Clinical, Patient History and Quality of Life Data from Boss and Aspect",Gut,2016,10.1136/gutjnl-2016-312388.234,https://experts.mcmaster.ca/display/publication695523,2025-07-27T15:10:54.978521
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Sa1199 Protease Inhibitors for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials,Gastrointestinal Endoscopy,2016,10.1016/j.gie.2016.03.363,https://experts.mcmaster.ca/display/publication684334,2025-07-27T15:10:54.978522
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies,Gastroenterology,2016,10.1016/s0016-5085(16)32524-0,https://experts.mcmaster.ca/display/publication522577,2025-07-27T15:10:54.978523
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Sa1085 Telephone vs. Clinic Follow-Up in the Management of Patients With Inflammatory Bowel Disease: A Nurse Practitioner Led Study,Gastroenterology,2016,10.1016/s0016-5085(16)30858-7,https://experts.mcmaster.ca/display/publication485111,2025-07-27T15:10:54.978524
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Anxiety and depression may lead to poor health-related quality of life in patients with inflammatory bowel disease,Journal of Crohn's and Colitis,2016,,https://experts.mcmaster.ca/display/publication485206,2025-07-27T15:10:54.978525
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Living with inflammatory bowel disease: results from focus group,Journal of Crohn's and Colitis,2016,,https://experts.mcmaster.ca/display/publication485186,2025-07-27T15:10:54.978526
Paul Moayyedi,moayyep@mcmaster.ca,conferences,P-079 YI The Association Between Anxiety and Depression and Health Related Quality of Life in Patients with Inflammatory Bowel Disease (IBD),Inflammatory Bowel Diseases,2016,10.1097/01.mib.0000480173.43285.d1,https://experts.mcmaster.ca/display/publication684370,2025-07-27T15:10:54.978526
Paul Moayyedi,moayyep@mcmaster.ca,conferences,P-231 YI Patient Experience Living with Inflammatory Bowel Disease,Inflammatory Bowel Diseases,2016,10.1097/01.mib.0000480346.99711.bc,https://experts.mcmaster.ca/display/publication684376,2025-07-27T15:10:54.978527
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Telephone vs clinic follow-up in the management of patients with inflammatory bowel disease: a nurse practitioner-led study,Journal of Crohn's and Colitis,2016,,https://experts.mcmaster.ca/display/publication485174,2025-07-27T15:10:54.978528
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk,Value in Health,2015,10.1016/j.jval.2015.09.2199,https://experts.mcmaster.ca/display/publication695590,2025-07-27T15:10:54.978529
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Effect of Antidepressants on Sleep in Functional Dyspepsia,American Journal of Gastroenterology,2015,10.14309/00000434-201510001-01744,https://experts.mcmaster.ca/display/publication695584,2025-07-27T15:10:54.978530
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Anxiety and Depression Increase in a Step-Wise Fashion in Parallel With Multiple FGIDs,Gastroenterology,2015,,https://experts.mcmaster.ca/display/publication522600,2025-07-27T15:10:54.978531
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Functional Dyspepsia Treatment Trial (FDTT): Association of Adequate Relief Response and Psychological Measures,Gastroenterology,2015,,https://experts.mcmaster.ca/display/publication695573,2025-07-27T15:10:54.978532
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Functional Dyspepsia Treatment Trial (FDTT): Effect of Antidepressants on Mood Response in Functional Dyspepsia,Gastroenterology,2015,,https://experts.mcmaster.ca/display/publication695594,2025-07-27T15:10:54.978533
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Gastric Physiology Test Correlations in Functional Dyspepsia,Gastroenterology,2015,,https://experts.mcmaster.ca/display/publication695575,2025-07-27T15:10:54.978534
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Increased Risk of Functional Gastrointestinal Disorders (FGIDs) in Obesity Patients,Gastroenterology,2015,,https://experts.mcmaster.ca/display/publication522592,2025-07-27T15:10:54.978535
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Is Proton Pump Inhibitor Use Associated With Delayed Gastric Emptying in Functional Dyspepsia Subjects?,Gastroenterology,2015,,https://experts.mcmaster.ca/display/publication695586,2025-07-27T15:10:54.978536
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"The Gut Microbiome in Patients with Anxiety, Depression and Inflammatory Bowel Disease",Neuropsychopharmacology,2014,,https://experts.mcmaster.ca/display/publication209131,2025-07-27T15:10:54.978537
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.",Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication209133,2025-07-27T15:10:54.978538
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Dermatological Complications of Anti-TNF-alpha Therapy in Crohn's Disease,Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication485200,2025-07-27T15:10:54.978539
Paul Moayyedi,moayyep@mcmaster.ca,conferences,GI Bowel Symptom Comorbidity in Functional Dyspepsia,Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication695612,2025-07-27T15:10:54.978540
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"In Functional Dyspepsia, Are Meal-Related Symptoms Linked to Less Drinking Capacity?",Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication695600,2025-07-27T15:10:54.978541
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia,Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication522565,2025-07-27T15:10:54.978542
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial,Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication209130,2025-07-27T15:10:54.978543
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Functional Dyspepsia Treatment Trial (FDTT): 5-HTT LPR and Gn beta 3 825C > T Are Not Pharmacogenetic Markers for FD Antidepressant Treatment Response,Gastroenterology,2014,,https://experts.mcmaster.ca/display/publication695582,2025-07-27T15:10:54.978544
Paul Moayyedi,moayyep@mcmaster.ca,conferences,P309 Transition experience from inpatient to ambulatory IBD care: Results of a pilot study,Journal of Crohn's and Colitis,2014,10.1016/s1873-9946(14)60430-x,https://experts.mcmaster.ca/display/publication684360,2025-07-27T15:10:54.978545
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Double Guidewire Technique for the Prevention of Post-ERCP Pancreatitis (PEP): Cochrane Collaboration Meta-analysis of RCTs,American Journal of Gastroenterology,2013,10.14309/00000434-201310001-00189,https://experts.mcmaster.ca/display/publication684427,2025-07-27T15:10:54.978546
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Psychosocial Characteristics of Patients With IBD: Experience From the Mcmaster Interdisciplinary Clinic,Gastroenterology,2013,,https://experts.mcmaster.ca/display/publication485254,2025-07-27T15:10:54.978546
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects,Gastroenterology,2013,,https://experts.mcmaster.ca/display/publication209132,2025-07-27T15:10:54.978547
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Functional Dyspepsia Treatment Trial (Fdtt) Key Results,Gastroenterology,2013,,https://experts.mcmaster.ca/display/publication695685,2025-07-27T15:10:54.978548
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Relationship Between Common IBD-Associated Risk Alleles and Intestinal Permeability in a Cohort of Healthy First Degree Relatives of Individuals With Crohn's Disease,Gastroenterology,2013,,https://experts.mcmaster.ca/display/publication209137,2025-07-27T15:10:54.978550
Paul Moayyedi,moayyep@mcmaster.ca,conferences,PPI and antiplatelet Co-therapy: What does the current evidence show?,Journal of Gastroenterology and Hepatology,2012,,https://experts.mcmaster.ca/display/publication695681,2025-07-27T15:10:54.978551
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Electrosurgical Current for Endoscopic Biliary Sphincterotomy (EBS) for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-analysis of Randomized Controlled Trials,American Journal of Gastroenterology,2012,10.14309/00000434-201210001-01767,https://experts.mcmaster.ca/display/publication684436,2025-07-27T15:10:54.978552
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Disordered Eating Behaviors in Functional Dyspepsia Patients,Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication695651,2025-07-27T15:10:54.978553
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report,Gut,2012,10.1136/gutjnl-2012-302084,https://experts.mcmaster.ca/display/publication1817621,2025-07-27T15:10:54.978554
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Risk of Serious (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Low-Dose Aspirin: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies",Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication684442,2025-07-27T15:10:54.978555
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant Non-Selective NSAID and Anticoagulation Therapy for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies",Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication684439,2025-07-27T15:10:54.978556
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Clopidogrel for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies",Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication684430,2025-07-27T15:10:54.978557
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Risk of Serious Upper Gastrointestinal (UGI) Complications With use of Non-Selective (NS) NSAIDs for at Least 4 Weeks Among Patients With a History of Peptic Ulcer (PU) or PU Complications: A Series of Systematic Reviews and Meta-Analyses,Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication684433,2025-07-27T15:10:54.978558
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Multiple Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials (RCT), Cohort and Case Control Studies",Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication684446,2025-07-27T15:10:54.978559
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies",Gastroenterology,2012,,https://experts.mcmaster.ca/display/publication684441,2025-07-27T15:10:54.978560
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Guidewire-Assisted Cannulation of the Common Bile Duct for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials,Gastrointestinal Endoscopy,2012,,https://experts.mcmaster.ca/display/publication684488,2025-07-27T15:10:54.978561
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Interdisciplinary, prompt access IBD clinic: The hamilton health science experience",Inflammatory Bowel Diseases,2011,10.1097/00054725-201112002-00017,https://experts.mcmaster.ca/display/publication684470,2025-07-27T15:10:54.978562
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Gender Differences in Psychologic Parameters in Functional Dyspepsia,American Journal of Gastroenterology,2011,10.14309/00000434-201110002-01320,https://experts.mcmaster.ca/display/publication695695,2025-07-27T15:10:54.978563
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Is the nutrient drink test associated with the patients' psychologic state?,Neurogastroenterology and Motility,2011,,https://experts.mcmaster.ca/display/publication695683,2025-07-27T15:10:54.978564
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Barrett's Dysplasia Cancer Task Force - Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus",Gastroenterology,2011,,https://experts.mcmaster.ca/display/publication446140,2025-07-27T15:10:54.978565
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Comparing the Quality of Reporting in Randomized Controlled Trial Abstracts at Two International Gastroenterology Meetings in 2010,Gastroenterology,2011,,https://experts.mcmaster.ca/display/publication695748,2025-07-27T15:10:54.978566
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Antidepressants in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis Controlling for Depression,Gastroenterology,2011,,https://experts.mcmaster.ca/display/publication695724,2025-07-27T15:10:54.978567
Paul Moayyedi,moayyep@mcmaster.ca,conferences,ROME III Criteria for Functional Gastrointestinal Disorders: Too Much Overlap to Be Useful?,Gastroenterology,2011,,https://experts.mcmaster.ca/display/publication695756,2025-07-27T15:10:54.978568
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of antidepressants in irritable bowel syndrome: an updated systematic review and meta-analysis controlling for depression,Gut,2011,10.1136/gut.2011.239301.328,https://experts.mcmaster.ca/display/publication695766,2025-07-27T15:10:54.978569
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Rome III criteria for functional gastrointestinal disorders: too much overlap to be useful?,Gut,2011,10.1136/gut.2011.239301.51,https://experts.mcmaster.ca/display/publication695738,2025-07-27T15:10:54.978570
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Determining the Optimum Outcome for Trials Evaluating Symptom Improvement in Functional Gastrointestinal Disorders,American Journal of Gastroenterology,2010,10.14309/00000434-201010001-01334,https://experts.mcmaster.ca/display/publication695758,2025-07-27T15:10:54.978571
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Effect of Comorbidity on Mortality in Patients with Peptic Ulcer Bleeding - A Systematic Review and Meta-Analysis,American Journal of Gastroenterology,2010,10.14309/00000434-201010001-00106,https://experts.mcmaster.ca/display/publication695736,2025-07-27T15:10:54.978572
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Quadruple Therapy Using a 3-in-1 Capsule of Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline with Omeprazole Compared to Triple Therapy for the Eradication of Helicobacter pylori: 2010 Presidential Poster",American Journal of Gastroenterology,2010,10.14309/00000434-201010001-00117,https://experts.mcmaster.ca/display/publication695728,2025-07-27T15:10:54.978573
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A Validation Study of the Italian Short-Form Leeds Dyspepsia Questionnaire,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175559,2025-07-27T15:10:54.978575
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy and Optimum Dose of Amino-Salicylic Acid (ASA) in Ulcerative Colitis (UC): A Meta-Analysis of Randomized Controlled Trials Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175560,2025-07-27T15:10:54.978576
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Amino-Salicylic Acid (ASA) in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175561,2025-07-27T15:10:54.978577
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Anti-TNF alpha Therapy in Ulcerative Colitis (UC): A Meta-Analysis of Randomized Controlled Trials Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175553,2025-07-27T15:10:54.978578
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Antibiotics at Inducing Remission in Active Ulcerative Colitis (UC): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs),Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175562,2025-07-27T15:10:54.978579
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Antibiotics in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials (RCTs) Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175555,2025-07-27T15:10:54.978580
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Biologics in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175557,2025-07-27T15:10:54.978581
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Budesonide in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials (RCTs) Assessing Remission Induction in Active Disease and Relapse Prevention in Quiescent Disease,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175550,2025-07-27T15:10:54.978585
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Improving Adherence to Guidelines When Managing Non-Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Strategy,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175558,2025-07-27T15:10:54.978587
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Incidence of Inflammatory Bowel Disease Following the Walkerton Outbreak of Waterborne Bacterial Gastroenteritis,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175556,2025-07-27T15:10:54.978587
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Placebo Response Rates in Trials of Pharmacological Therapies for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175551,2025-07-27T15:10:54.978588
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Gamma-Aminobutyric Acid (GABA) Receptor Agonist Baclofen in the Treatment of Gastroesophageal Reflux Disease (GERD): A Systematic Review,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175567,2025-07-27T15:10:54.978589
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Practice of North-American Gastroenterologists in Treating IBD Patients With C.Difficile: Antibiotics Alone or Combined Antibiotics-Immunomodulators?,Gastroenterology,2010,,https://experts.mcmaster.ca/display/publication2175554,2025-07-27T15:10:54.978590
Paul Moayyedi,moayyep@mcmaster.ca,conferences,P.30 A VALIDATION STUDY OF THE ITALIAN SHORT-FORM LEEDS DYSPEPSIA QUESTIONNAIRE,Digestive and Liver Disease,2010,10.1016/s1590-8658(10)60144-2,https://experts.mcmaster.ca/display/publication695744,2025-07-27T15:10:54.978591
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Does Proton Pump Inhibitor (PPI) Treatment Initiated Before Endoscopy Work in Unselected Upper Gastrointestinal Bleeding? A Cochrane Systematic Review Update,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695886,2025-07-27T15:10:54.978592
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Effect of Validation Status and Type of Dyspepsia Questionnaire On the Prevalence of Dyspepsia: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695842,2025-07-27T15:10:54.978593
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695806,2025-07-27T15:10:54.978594
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Post-Infective Dyspepsia Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE),Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication485481,2025-07-27T15:10:54.978595
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Prevalence of Clinically Significant Endoscopic Findings in Individuals with and Without Dyspepsia: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695814,2025-07-27T15:10:54.978596
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Prevalence of Irritable Bowel Syndrome in Individuals with Dyspepsia: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695848,2025-07-27T15:10:54.978597
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Prevalence of Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695810,2025-07-27T15:10:54.978598
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Prognosis of Post-Infectious Irritable Bowel Syndrome (PI-IBS) Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE),Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication485425,2025-07-27T15:10:54.978599
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695808,2025-07-27T15:10:54.978600
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Risk Factors for Dyspepsia: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695850,2025-07-27T15:10:54.978601
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695836,2025-07-27T15:10:54.978602
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Worldwide Prevalence of Dyspepsia: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695846,2025-07-27T15:10:54.978603
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"What Is the Optimum Duration of Proton Pump Inhibitor (PPI)-Based Triple Therapy for Helicobacter pylori? 7, 10, or 14 Days?",Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695820,2025-07-27T15:10:54.978604
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Yield of Diagnostic Tests for Celiac Disease in Dyspepsia: Systematic Review and Meta-Analysis,Gastroenterology,2009,,https://experts.mcmaster.ca/display/publication695822,2025-07-27T15:10:54.978605
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of 5HT3-Antagonists in non-constipation predominant irritable bowel syndrome: systematic review and meta-analysis,American Journal of Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695840,2025-07-27T15:10:54.978606
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of 5HT4-Agonists in Non-Diarrhea Predominant Irritable Bowel Syndrome,American Journal of Gastroenterology,2008,10.14309/00000434-200809001-01222,https://experts.mcmaster.ca/display/publication695402,2025-07-27T15:10:54.978607
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of Antidepressants in Irritable Bowel Syndrome,American Journal of Gastroenterology,2008,10.14309/00000434-200809001-01218,https://experts.mcmaster.ca/display/publication695411,2025-07-27T15:10:54.978608
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Efficacy of antispasmodics and peppermint oil in irritable bowel syndrome: Systematic review and meta-analysis,American Journal of Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695826,2025-07-27T15:10:54.978609
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The Efficacy of Probiotics in the Therapy of Irritable Bowel Syndrome (IBS),American Journal of Gastroenterology,2008,10.14309/00000434-200809001-01230,https://experts.mcmaster.ca/display/publication695417,2025-07-27T15:10:54.978610
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Triple Versus Quadruple Therapy as Primary Treatment for Heliobacter pylori Infection,American Journal of Gastroenterology,2008,10.14309/00000434-200809001-01015,https://experts.mcmaster.ca/display/publication695399,2025-07-27T15:10:54.978611
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Utility of Diagnostic Tests for Celiac Disease in Irritable Bowel Syndrome,American Journal of Gastroenterology,2008,10.14309/00000434-200809001-01185,https://experts.mcmaster.ca/display/publication695403,2025-07-27T15:10:54.978612
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Empirical proton pump inhibitor therapy or Helicobacter pylori ""test and treat"" in the initial management of dyspepsia? An individual patient data meta-analysis",Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695416,2025-07-27T15:10:54.978613
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Fluctuation of gastrointestinal symptoms in the community: A 10-year longitudinal survey,Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695828,2025-07-27T15:10:54.978614
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori eradication reduces the incidence of gastric cancer: Results of a systematic review of randomized controlled trials,Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695418,2025-07-27T15:10:54.978615
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Systematic review and meta-analysis of the saftey of bismuth,Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695812,2025-07-27T15:10:54.978616
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Systematic review of the utility of the manning and ROME criteria in the diagnosis of irritable bowel syndrome,Gastroenterology,2008,,https://experts.mcmaster.ca/display/publication695404,2025-07-27T15:10:54.978617
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Economic Reflections on Proton Pump Inhibitor Therapy for Non-Erosive Reflux Disease,Digestion,2008,10.1159/000151257,https://experts.mcmaster.ca/display/publication695082,2025-07-27T15:10:54.978618
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Non-Erosive Reflux Disease – Defining the Entity and Delineating the Management,Digestion,2008,10.1159/000151248,https://experts.mcmaster.ca/display/publication695115,2025-07-27T15:10:54.978619
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori and related disease,Journal of Gastroenterology and Hepatology,2007,,https://experts.mcmaster.ca/display/publication695420,2025-07-27T15:10:54.978620
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Who Pays the Piper?,Journal of Clinical Gastroenterology,2007,10.1097/mcg.0b013e31803238e7,https://experts.mcmaster.ca/display/publication695401,2025-07-27T15:10:54.978621
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A cross-sectional survey to assess the usefulness of the Rome III dyspepsia symptom subgroups in a large community sample,Gastroenterology,2007,,https://experts.mcmaster.ca/display/publication695414,2025-07-27T15:10:54.978622
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A cross-sectional survey to assess the usefulness of the rome III dyspepsia symptom subgroups in a large community sample,Gut,2007,,https://experts.mcmaster.ca/display/publication695413,2025-07-27T15:10:54.978623
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Endoscopic Ultrasound: A Meta-Analysis of Test Performance in Suspected Choledocholithiasis,Gastrointestinal Endoscopy,2007,10.1016/j.gie.2007.03.932,https://experts.mcmaster.ca/display/publication684338,2025-07-27T15:10:54.978624
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomised, double-blind, placebo-controlled multicentre study",Gut,2007,,https://experts.mcmaster.ca/display/publication695419,2025-07-27T15:10:54.978625
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomized, double-blind, placebo-controlled multicenter study",Gastroenterology,2007,,https://experts.mcmaster.ca/display/publication695412,2025-07-27T15:10:54.978626
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Evaluation of symptom relief after 1 week of esomeprazole therapy as a predictor of relief after 4 weeks in patients with unexplained chest pain: A randomized, double-blind, placebo-controlled, multicenter study",Gastroenterology,2007,,https://experts.mcmaster.ca/display/publication695406,2025-07-27T15:10:54.978626
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Herbal medicine for the treatment of functional dyspepsia: A systematic review of the literature and meta-analysis,Gastroenterology,2007,,https://experts.mcmaster.ca/display/publication695408,2025-07-27T15:10:54.978627
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Poor quality of life predicts the new onset of irritable bowel syndrome. A longitudinal 10-year follow-up study,Gut,2007,,https://experts.mcmaster.ca/display/publication695415,2025-07-27T15:10:54.978628
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Poor quality of life predicts the new onset of irritable bowel syndrome. A longitudinal ten-year follow-up study,Gastroenterology,2007,,https://experts.mcmaster.ca/display/publication695405,2025-07-27T15:10:54.978629
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Who consults with irritable bowel syndrome? A longitudinal 10-year follow-up study,Gut,2007,,https://experts.mcmaster.ca/display/publication695410,2025-07-27T15:10:54.978630
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A 10 year natural history of gastrooesophageal reflux disease,Gut,2006,,https://experts.mcmaster.ca/display/publication695830,2025-07-27T15:10:54.978631
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A cross sectional survey of the relationship between gastrooesophageal reflux disease and chronic cough,Gut,2006,,https://experts.mcmaster.ca/display/publication695445,2025-07-27T15:10:54.978632
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A ten-year natural history of gastro-esophageal reflux disease,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695443,2025-07-27T15:10:54.978633
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Effect of sibling number and birth order on Helicobacter pylori prevalence: A cross sectional survey,Gut,2006,,https://experts.mcmaster.ca/display/publication695904,2025-07-27T15:10:54.978634
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Effect of sibling number and birth order on prevalence of Helicobacter pylori a cross-sectional survey,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695465,2025-07-27T15:10:54.978635
Paul Moayyedi,moayyep@mcmaster.ca,conferences,H-pylori eradication v empirical acid suppression in uninvestigated H-pylori positive dyspepsia: A Cochrane Collaboration individual patient data meta-analysis,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695463,2025-07-27T15:10:54.978636
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori infection confers an increase in 10 year mortality from all causes: Data from a community screening programme,Gut,2006,,https://experts.mcmaster.ca/display/publication695439,2025-07-27T15:10:54.978637
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori infection confers an increase in ten-year mortality from all causes: Data from a community screening and treatment program,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695455,2025-07-27T15:10:54.978638
Paul Moayyedi,moayyep@mcmaster.ca,conferences,High dose versus standard dose proton pump inhibitors in the short term management of reflux esophagitis,Cochrane Database of Systematic Reviews,2006,10.1002/14651858.cd010581,https://experts.mcmaster.ca/display/publication695461,2025-07-27T15:10:54.978639
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in unselected upper gastrointestinal bleeding: A cochrane systematic review and meta-analysis,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695429,2025-07-27T15:10:54.978640
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Systematic review of adenocarcinoma risk in Barrett's esophagus with particular reference to short segment Barrett's esophagus and intestinal metaplasia,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695427,2025-07-27T15:10:54.978641
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Targeted esophageal biopsies: What you see is what you get (WYSIWYG) - Or not?,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695431,2025-07-27T15:10:54.978642
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Who consults with dyspepsia? A 10 year cross sectional survey,Gut,2006,,https://experts.mcmaster.ca/display/publication695447,2025-07-27T15:10:54.978643
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Who consults with dyspepsia? A ten-year cross-sectional survey,Gastroenterology,2006,,https://experts.mcmaster.ca/display/publication695449,2025-07-27T15:10:54.978644
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A community screening and treatment programme for H-pylori saves money: Ten-year follow-up of a randomized controlled trial,Gastroenterology,2005,,https://experts.mcmaster.ca/display/publication695423,2025-07-27T15:10:54.978645
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review of the diagnosis of functional dyspepsia,Gastroenterology,2005,,https://experts.mcmaster.ca/display/publication695422,2025-07-27T15:10:54.978646
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Ten year follow-up of a community screening and treatment programme for H pylori,Gut,2005,,https://experts.mcmaster.ca/display/publication695506,2025-07-27T15:10:54.978647
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The diagnostic value of alarm features in predicting upper gastrointestinal malignancy in dyspeptic patients: Systematic review and meta-analysis.,Gastroenterology,2005,,https://experts.mcmaster.ca/display/publication695425,2025-07-27T15:10:54.978648
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004,Canadian Journal of Gastroenterology and Hepatology,2005,10.1155/2005/836030,https://experts.mcmaster.ca/display/publication485565,2025-07-27T15:10:54.978649
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A retrospective case control study to determine the risk of Barrett's oesophagus according to ethnic origin,Gut,2004,,https://experts.mcmaster.ca/display/publication695663,2025-07-27T15:10:54.978649
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A retrospective case-control study to determine the risk of Barrett's esophagus according to ethnic origin,Gastroenterology,2004,,https://experts.mcmaster.ca/display/publication695604,2025-07-27T15:10:54.978650
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Methodologic quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia: A meta-analysis based on two methodologic criteria scores,Gastroenterology,2004,,https://experts.mcmaster.ca/display/publication695580,2025-07-27T15:10:54.978651
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Mortality risk factors and comorbidity in patients with Barrett's metaplasia,Gut,2004,,https://experts.mcmaster.ca/display/publication695592,2025-07-27T15:10:54.978652
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Prompt endoscopy versus a 'test and treat' strategy in the initial management of dyspepsia: An individual patient data meta-analysis of randomized controlled trials,Gastroenterology,2004,,https://experts.mcmaster.ca/display/publication695569,2025-07-27T15:10:54.978653
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"The long-term natural history of dyspepsia, and the importance of the irritable bowel syndrome",Gastroenterology,2004,,https://experts.mcmaster.ca/display/publication695608,2025-07-27T15:10:54.978654
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review and economic analysis of the cost-effectiveness of proton pump inhibitor therapy in non-ulcer dyspepsia,Gut,2003,,https://experts.mcmaster.ca/display/publication695732,2025-07-27T15:10:54.978655
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review and economic analysis of the cost-effectiveness of proton pump inhibitor therapy in non-ulcer dyspepsia,Gastroenterology,2003,10.1016/s0016-5085(03)80906-x,https://experts.mcmaster.ca/display/publication695734,2025-07-27T15:10:54.978656
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review of Helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance,Gastroenterology,2003,10.1016/s0016-5085(03)81812-7,https://experts.mcmaster.ca/display/publication695655,2025-07-27T15:10:54.978657
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review of helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance,Gut,2003,,https://experts.mcmaster.ca/display/publication695722,2025-07-27T15:10:54.978658
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"A systematic review of the efficacy of proton pump inhibitors (PPIs), H2 receptor antagonists (H2RAs) and prokinetics in maintenance therapy of esophagitis",Gastroenterology,2003,10.1016/s0016-5085(03)80534-6,https://experts.mcmaster.ca/display/publication695762,2025-07-27T15:10:54.978660
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Cost effectiveness of h pylori ""test and treat"" versus PPI for uninvestigated dyspepsia: Modelling and meta-analysis in the design of the MRC-CUBE trial",Gut,2003,,https://experts.mcmaster.ca/display/publication695740,2025-07-27T15:10:54.978661
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Early diagnosis or prevention of gastric cancer with H.pylori ȁTest and treatȁ? A discrete event simulation model,Gastroenterology,2003,10.1016/s0016-5085(03)80900-9,https://experts.mcmaster.ca/display/publication695760,2025-07-27T15:10:54.978662
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Gastroesophageal reflux is more prominent in western dyspeptics: A prospective comparison study of British and South East Asian patients with dyspepsia,Gastroenterology,2003,10.1016/s0016-5085(03)80836-3,https://experts.mcmaster.ca/display/publication695730,2025-07-27T15:10:54.978663
Paul Moayyedi,moayyep@mcmaster.ca,conferences,How best to assess symptomatic outcomes of therapy in gastro-oesophageal reflux disease trials: A systematic review,Gastroenterology,2003,10.1016/s0016-5085(03)80355-4,https://experts.mcmaster.ca/display/publication695720,2025-07-27T15:10:54.978663
Paul Moayyedi,moayyep@mcmaster.ca,conferences,How best to assess symptomatic outcomes of therapy in gastro-oesophageal reflux disease trials: A systematic review,Gut,2003,,https://experts.mcmaster.ca/display/publication695752,2025-07-27T15:10:54.978664
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Survey of current clinical practice in the diagnosis, management and surveillance of Barrett's metaplasia: A UK national survey",Gut,2003,,https://experts.mcmaster.ca/display/publication695768,2025-07-27T15:10:54.978665
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The value of drugs to treat upper gastrointestinal symptoms: What are patients willing to pay?,Gut,2003,,https://experts.mcmaster.ca/display/publication695754,2025-07-27T15:10:54.978666
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Validation of the short-form leeds dyspepsia questionnaire (SF-LDQ) in a community setting,Gastroenterology,2003,10.1016/s0016-5085(03)81126-5,https://experts.mcmaster.ca/display/publication695675,2025-07-27T15:10:54.978667
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori eradication in non-ulcer dyspepsia: the case for,HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002,2003,,https://experts.mcmaster.ca/display/publication695541,2025-07-27T15:10:54.978668
Paul Moayyedi,moayyep@mcmaster.ca,conferences,How can the current strategies for eradication therapy be improved?,HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002,2003,,https://experts.mcmaster.ca/display/publication695000,2025-07-27T15:10:54.978669
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Clinical and economic consequences of dyspepsia in the community,Gut,2002,10.1136/gut.50.suppl_4.iv10,https://experts.mcmaster.ca/display/publication695178,2025-07-27T15:10:54.978670
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori test and treat strategy for young dyspeptic patients: new data,Gut,2002,10.1136/gut.50.suppl_4.iv47,https://experts.mcmaster.ca/display/publication695742,2025-07-27T15:10:54.978671
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A comparison of systematic reviews of Helicobacter pylori eradication for non-ulcer dyspepsia,Gut,2002,,https://experts.mcmaster.ca/display/publication695854,2025-07-27T15:10:54.978672
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The effect of reduced duality of life on the subsequent development of dyspepsia and irritable bowel syndrome: A prospective cohort study,Gastroenterology,2002,,https://experts.mcmaster.ca/display/publication695844,2025-07-27T15:10:54.978673
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The effect of reduced quality of life on the subsequent development of dyspepsia and irritable bowel syndrome: A prospective cohort study,Gut,2002,,https://experts.mcmaster.ca/display/publication695838,2025-07-27T15:10:54.978674
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The influence of antibiotics on irritable bowel syndrome: A randomised controlled trial,Gut,2002,,https://experts.mcmaster.ca/display/publication695818,2025-07-27T15:10:54.978675
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The influence of antibiotics on irritable bowel syndrome: A randomised controlled trial,Gastroenterology,2002,,https://experts.mcmaster.ca/display/publication695832,2025-07-27T15:10:54.978676
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Patient preference and willingness to pay for helicobacter stool antigen test compared to breath test,Gut,2001,,https://experts.mcmaster.ca/display/publication695890,2025-07-27T15:10:54.978677
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori: A clinical update,Journal of Applied Bacteriology Symposium Supplement,2001,,https://experts.mcmaster.ca/display/publication1747281,2025-07-27T15:10:54.978678
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Effectiveness of prompt endoscopy in the management of dyspepsia: A systematic review.,Gastroenterology,2001,,https://experts.mcmaster.ca/display/publication695182,2025-07-27T15:10:54.978679
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The appropriateness of measuring the benefit of dyspepsia management in terms of quality adjusted life years,Gastroenterology,2001,,https://experts.mcmaster.ca/display/publication695884,2025-07-27T15:10:54.978680
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The appropriateness of measuring the benefit of dyspepsia management in terms of quality adjusted life years,Gut,2001,,https://experts.mcmaster.ca/display/publication695900,2025-07-27T15:10:54.978681
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review and economic analysis of the cost-effectiveness of H pylori eradication therapy in non-ulcer dyspepsia (NUD),Gastroenterology,2000,10.1016/s0016-5085(00)84002-0,https://experts.mcmaster.ca/display/publication695529,2025-07-27T15:10:54.978682
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review and economic analysis of the cost-effectiveness of H pylori eradication therapy in non-ulcer dyspepsia (NUD),Gut,2000,,https://experts.mcmaster.ca/display/publication695535,2025-07-27T15:10:54.978683
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review of pharmacological therapies in non-ulcer dyspepsia,Gastroenterology,2000,10.1016/s0016-5085(00)83871-8,https://experts.mcmaster.ca/display/publication695543,2025-07-27T15:10:54.978684
Paul Moayyedi,moayyep@mcmaster.ca,conferences,A systematic review of pharmacological therapies in non-ulcer dyspepsia.,Gut,2000,,https://experts.mcmaster.ca/display/publication695545,2025-07-27T15:10:54.978685
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Cost-effectiveness of strategies for managing dyspepsia in primary care: A discrete event simulation,Gastroenterology,2000,10.1016/s0016-5085(00)83990-6,https://experts.mcmaster.ca/display/publication695539,2025-07-27T15:10:54.978686
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Diagnosis of helicobacter pylori infection in acute upper gastrointestinal haemorrhage; what is the best diagnostic test?,Gastroenterology,2000,10.1016/s0016-5085(00)80819-7,https://experts.mcmaster.ca/display/publication695433,2025-07-27T15:10:54.978687
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Establishing patient preferences for one-stop gastrointestinal clinics using conjoint analysis,Gastroenterology,2000,10.1016/s0016-5085(00)85017-9,https://experts.mcmaster.ca/display/publication695467,2025-07-27T15:10:54.978688
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Establishing patient preferences for one-stop gastrointestinal clinics using conjoint analysis,Gut,2000,,https://experts.mcmaster.ca/display/publication695537,2025-07-27T15:10:54.978689
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"How much are dyspeptic patients willing to pay for endoscopy compared with H pylori ""test and treat"" service?",Gut,2000,,https://experts.mcmaster.ca/display/publication695551,2025-07-27T15:10:54.978690
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"How much are patients with dyspepsia willing to pay for endoscopy compared with an H pylori ""test and treat"" service?",Gastroenterology,2000,10.1016/s0016-5085(00)83962-1,https://experts.mcmaster.ca/display/publication695512,2025-07-27T15:10:54.978691
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Knowledge of a negative C-13-urea breath test reduces health care utilisation for dyspepsia in a population H pylori test and treat program.,Gastroenterology,2000,,https://experts.mcmaster.ca/display/publication695517,2025-07-27T15:10:54.978692
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Managing dyspepsia in primary care: A systematic review,Gastroenterology,2000,10.1016/s0016-5085(00)80839-2,https://experts.mcmaster.ca/display/publication695441,2025-07-27T15:10:54.978693
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Supine duodeno-gastro-oesophageal bile reflux measured with the Bilitec-2000 appears to protect against the presence of microscopic intestinal metaplasia at the cardia,Gastroenterology,2000,10.1016/s0016-5085(00)82172-1,https://experts.mcmaster.ca/display/publication695547,2025-07-27T15:10:54.978694
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The cost-effectiveness of population H pylori screening and treatment to reduce mortality from gastric cancer and peptic ulcer complications: A Markov model using randomized controlled trial data.,Gastroenterology,2000,,https://experts.mcmaster.ca/display/publication695451,2025-07-27T15:10:54.978694
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The prevalence of Helicobacter pylori in bleeding peptic ulcer disease,Gut,1999,,https://experts.mcmaster.ca/display/publication695953,2025-07-27T15:10:54.978695
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Accuracy of a new antigen based stool test for Helicobacter pylori (HP) in 117 endoscoped patients before and after treatment, European multicentre study.",Gut,1999,,https://experts.mcmaster.ca/display/publication695967,2025-07-27T15:10:54.978696
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Addition of metronidazole to omeprazole and amoxicillin for second line H pylori eradication does not influence eradication rate: Results of a single-blinded randomised trial,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication696057,2025-07-27T15:10:54.978697
Paul Moayyedi,moayyep@mcmaster.ca,conferences,An evidence-based appraisal of reflux disease management --- the Genval Workshop Report,Gut,1999,10.1136/gut.44.2008.s1,https://experts.mcmaster.ca/display/publication1466935,2025-07-27T15:10:54.978698
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Changing patterns of H pylori gastritis in long-standing acid suppression,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication695892,2025-07-27T15:10:54.978699
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Changing patterns of H-pylori gastritis in long-standing acid suppression,Gut,1999,,https://experts.mcmaster.ca/display/publication695880,2025-07-27T15:10:54.978700
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomised double blind study,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication696034,2025-07-27T15:10:54.978701
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomised double blind study.,Gut,1999,,https://experts.mcmaster.ca/display/publication695400,2025-07-27T15:10:54.978702
Paul Moayyedi,moayyep@mcmaster.ca,conferences,H pylori screening and treatment reduces dyspepsia in the community,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication696044,2025-07-27T15:10:54.978703
Paul Moayyedi,moayyep@mcmaster.ca,conferences,H pylori screening and treatment reduces dyspepsia in the community.,Gut,1999,,https://experts.mcmaster.ca/display/publication695949,2025-07-27T15:10:54.978704
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Population H pylori screening and treatment reduces dyspepsia costs.,Gut,1999,,https://experts.mcmaster.ca/display/publication695951,2025-07-27T15:10:54.978705
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Population H pylori screening and treatment reduces dyspepsia costs.,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication695959,2025-07-27T15:10:54.978706
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Second-line eradication for H-pylori after failure of therapy with proton pump inhibitor (PPI), clarithromycin and metronidazole: Results of a case series",Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication696042,2025-07-27T15:10:54.978707
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Second-line eradication for H-pylori after failure of therapy with proton pump inhibitor (PPI), clarithromycin and metronidazole: Results of a case series.",Gut,1999,,https://experts.mcmaster.ca/display/publication695961,2025-07-27T15:10:54.978708
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for H-pylori eradication - Results of a single-blinded randomised trial in the community,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication696046,2025-07-27T15:10:54.978709
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for H-pylori eradication - Results of a single-blinded randomised trial in the community.,Gut,1999,,https://experts.mcmaster.ca/display/publication695997,2025-07-27T15:10:54.978710
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The cost-effectiveness of an H pylori screen and treat strategy in dyspeptic patients presenting in primary care,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication695912,2025-07-27T15:10:54.978711
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The cost-effectiveness of an H-Pylori screen and treat strategy in dyspeptic patients presenting in primary care.,Gut,1999,,https://experts.mcmaster.ca/display/publication695963,2025-07-27T15:10:54.978711
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The prevalence and severity of irritable bowel syndrome (IBS) in the community in those with and without a primary care diagnosis,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication695993,2025-07-27T15:10:54.978712
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The prevalence and severity of irritable bowel syndrome (IBS) in the community in those with and without a primary care diagnosis.,Gut,1999,,https://experts.mcmaster.ca/display/publication695977,2025-07-27T15:10:54.978713
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Why do irritable bowel syndrome (IBS) sufferers visit a primary care physician?,Gastroenterology,1999,,https://experts.mcmaster.ca/display/publication696059,2025-07-27T15:10:54.978714
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Screening and treating for H-pylori - Is it cost-effective in clinical practice?,Gut,1998,,https://experts.mcmaster.ca/display/publication696048,2025-07-27T15:10:54.978715
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Any role left for invasive tests? Histology in clinical practice,Gut,1998,10.1136/gut.43.2008.s51,https://experts.mcmaster.ca/display/publication695453,2025-07-27T15:10:54.978716
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"The effectiveness and side effects of omeprazole, clarithromycin and tinidazole used in a community Helicobacter pylori eradication programme.",Gastroenterology,1998,,https://experts.mcmaster.ca/display/publication696065,2025-07-27T15:10:54.978717
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community.",Gastroenterology,1998,,https://experts.mcmaster.ca/display/publication696061,2025-07-27T15:10:54.978718
Paul Moayyedi,moayyep@mcmaster.ca,conferences,What proportion of dyspepsia in the general population is attributable to Helicobacter pylori?,Gastroenterology,1998,,https://experts.mcmaster.ca/display/publication696050,2025-07-27T15:10:54.978719
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Can pets ACT as a vector for Helicobacter pylori transmission?,Gastroenterology,1998,10.1016/s0016-5085(98)80935-9,https://experts.mcmaster.ca/display/publication695995,2025-07-27T15:10:54.978720
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Response to pantoprazole is an effective diagnostic test for gastro-esophageal reflux disease: Results of a randomised double-blinded placebo-controlled pilot study,Gastroenterology,1998,10.1016/s0016-5085(98)80983-9,https://experts.mcmaster.ca/display/publication696022,2025-07-27T15:10:54.978721
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Can pets act as a vector for Helicobacter pylori transmission?,Gut,1998,,https://experts.mcmaster.ca/display/publication695983,2025-07-27T15:10:54.978722
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The effectiveness and side effects of a community Helicobacter pylori eradication programme.,Gut,1998,,https://experts.mcmaster.ca/display/publication695957,2025-07-27T15:10:54.978723
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community.",Gut,1998,,https://experts.mcmaster.ca/display/publication695750,2025-07-27T15:10:54.978724
Paul Moayyedi,moayyep@mcmaster.ca,conferences,What proportion of dyspepsia in the general population is attributable to Helicobacter pylori?,Gut,1998,,https://experts.mcmaster.ca/display/publication695973,2025-07-27T15:10:54.978725
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Effectiveness of omeprazole, clarithromycin and tinidazole against Helicobacter pylori in a community screening and eradication programme",Gut,1997,,https://experts.mcmaster.ca/display/publication695969,2025-07-27T15:10:54.978726
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Evidence for intrafamilial transmission of Helicobacter pylori infection in adults,Gut,1997,,https://experts.mcmaster.ca/display/publication695965,2025-07-27T15:10:54.978727
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Helicobacter pylori and the risk of stroke,Gut,1997,,https://experts.mcmaster.ca/display/publication695987,2025-07-27T15:10:54.978728
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Influence of Helicobacter pylori status on adult height,Gut,1997,,https://experts.mcmaster.ca/display/publication695985,2025-07-27T15:10:54.978729
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Isolation of H-pylori from gastric juice,Gut,1997,,https://experts.mcmaster.ca/display/publication695989,2025-07-27T15:10:54.978730
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Validation of a new one-step near patient Helicobacter pylori test,Gut,1997,,https://experts.mcmaster.ca/display/publication695870,2025-07-27T15:10:54.978731
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Accuracy of the Helisal rapid blood kit and its use in pre-endoscopic screening,Gut,1997,,https://experts.mcmaster.ca/display/publication695981,2025-07-27T15:10:54.978732
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Evidence for intrafamilial transmission of Helicobacter pylori infection in adults,Gut,1997,,https://experts.mcmaster.ca/display/publication695979,2025-07-27T15:10:54.978733
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Isolation of H-pylori from gastric juice,Gut,1997,,https://experts.mcmaster.ca/display/publication696038,2025-07-27T15:10:54.978734
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Validation of a new one-step near patient Helicobacter pylori test,Gut,1997,,https://experts.mcmaster.ca/display/publication695975,2025-07-27T15:10:54.978735
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Adult social class as an independent risk factor for Helicobacter pylori.,Gastroenterology,1997,,https://experts.mcmaster.ca/display/publication696032,2025-07-27T15:10:54.978736
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Dyspepsia and irritable bowel syndrome in the community.,Gastroenterology,1997,,https://experts.mcmaster.ca/display/publication695339,2025-07-27T15:10:54.978737
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Influence of siblings on risk of Helicobacter pylori infection.,Gastroenterology,1997,,https://experts.mcmaster.ca/display/publication695383,2025-07-27T15:10:54.978738
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The optimum 5 day therapy against Helicobacter pylori.,Gastroenterology,1997,,https://experts.mcmaster.ca/display/publication695365,2025-07-27T15:10:54.978739
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Adult social class as an independent risk factor for Helicobacter pylori.,Gut,1997,,https://experts.mcmaster.ca/display/publication696067,2025-07-27T15:10:54.978740
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Dyspepsia and irritable bowel syndrome in the community.,Gut,1997,,https://experts.mcmaster.ca/display/publication696028,2025-07-27T15:10:54.978740
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Influence of siblings on risk of Helicobacter pylori infection.,Gut,1997,,https://experts.mcmaster.ca/display/publication696040,2025-07-27T15:10:54.978741
Paul Moayyedi,moayyep@mcmaster.ca,conferences,The optimum 5 day therapy against Helicobacter pylori.,Gut,1997,,https://experts.mcmaster.ca/display/publication696054,2025-07-27T15:10:54.978742
Paul Moayyedi,moayyep@mcmaster.ca,conferences,Eradication ofHelicobacter pylori: Omeprazole in Combination with Antibiotics,Scandinavian Journal of Gastroenterology,1996,10.3109/00365529609094542,https://experts.mcmaster.ca/display/publication695341,2025-07-27T15:10:54.978743
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Whom, how and when to test for Helicobacter pylori infection",HELICOBACTER PYLORI,1996,,https://experts.mcmaster.ca/display/publication695397,2025-07-27T15:10:54.978744
Paul Moayyedi,moayyep@mcmaster.ca,conferences,"Efficacy of ten days of clarithromycin, amoxicillin and omeprazole in eradicating Helicobacter pylori infection",Gastroenterology,1995,10.1016/0016-5085(95)23338-5,https://experts.mcmaster.ca/display/publication696030,2025-07-27T15:10:54.978745
Paul Moayyedi,moayyep@mcmaster.ca,other,GI Epidemiology,,2014,10.1002/9781118727072,https://experts.mcmaster.ca/display/publication1747275,2025-07-27T15:10:54.978746
Paul Moayyedi,moayyep@mcmaster.ca,preprints,"Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility",,2021,10.1101/2021.06.15.21258641,https://experts.mcmaster.ca/display/publication3234356,2025-07-27T15:10:54.978747
